{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T14:26:46Z","timestamp":1795012006422,"version":"4.9.1"},"reference-count":280,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2022,10,3]],"date-time":"2022-10-03T00:00:00Z","timestamp":1664755200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,10,3]],"date-time":"2022-10-03T00:00:00Z","timestamp":1664755200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Assist Reprod Genet"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1007\/s10815-022-02625-7","type":"journal-article","created":{"date-parts":[[2022,10,3]],"date-time":"2022-10-03T01:02:18Z","timestamp":1664758938000},"page":"2439-2473","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":340,"title":["A brief insight into the etiology, genetics, and immunology of polycystic ovarian syndrome (PCOS)"],"prefix":"10.1007","volume":"39","author":[{"given":"Sana","family":"Siddiqui","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Somaiya","family":"Mateen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rizwan","family":"Ahmad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2116-4832","authenticated-orcid":false,"given":"Shagufta","family":"Moin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,10,3]]},"reference":[{"key":"2625_CR1","unstructured":"A. Szilagyi and I. Szabo, \u201cEndocrine characteristics of polycystic ovary syndrome (PCOS),\u201d IJEB Vol.41(07) [July 2003], 2003, Accessed: Jan. 18, 2022. [Online]. Available: http:\/\/nopr.niscair.res.in\/handle\/123456789\/17119"},{"issue":"6","key":"2625_CR2","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1093\/HUMUPD\/DMW025","volume":"22","author":"AH Balen","year":"2016","unstructured":"Balen AH, et al. The management of anovulatory infertility in women with polycystic ovary syndrome: an analysis of the evidence to support the development of global WHO guidance. Hum Reprod Update. 2016;22(6):687\u2013708. https:\/\/doi.org\/10.1093\/HUMUPD\/DMW025.","journal-title":"Hum Reprod Update"},{"issue":"5","key":"2625_CR3","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/nrendo.2018.24","volume":"14","author":"HF Escobar-Morreale","year":"2018","unstructured":"Escobar-Morreale HF. Polycystic ovary syndrome: definition, aetiology, diagnosis and treatment. Nature Rev Endocrinol. 2018;14(5):270\u201384.","journal-title":"Nature Rev Endocrinol"},{"key":"2625_CR4","doi-asserted-by":"publisher","unstructured":"R. Azziz et al., \u201cPolycystic ovary syndrome,\u201d Nature Reviews Disease Primers 2016 2:1 https:\/\/doi.org\/10.1038\/nrdp.2016.57.","DOI":"10.1038\/nrdp.2016.57"},{"issue":"8","key":"2625_CR5","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1210\/JS.2019-00078","volume":"3","author":"SF Witchel","year":"2019","unstructured":"Witchel SF, Oberfield SE, Pe\u00f1a AS. Polycystic ovary syndrome: pathophysiology, presentation, and treatment with emphasis on adolescent girls. J Endocr Soc. 2019;3(8):1545\u201373. https:\/\/doi.org\/10.1210\/JS.2019-00078.","journal-title":"J Endocr Soc"},{"issue":"3","key":"2625_CR6","doi-asserted-by":"publisher","first-page":"319","DOI":"10.4103\/JOD.JOD_105_20","volume":"12","author":"TS Mehreen","year":"2022","unstructured":"Mehreen TS, Ranjani H, Kamalesh R, Ram U, Anjana RM, Mohan V. Prevalence of polycystic ovarian syndrome among adolescents and young women in India. J Diabetol. 2022;12(3):319. https:\/\/doi.org\/10.4103\/JOD.JOD_105_20.","journal-title":"J Diabetol"},{"key":"2625_CR7","doi-asserted-by":"publisher","unstructured":"M. F. Yii, C. E. D. Lim, X. Luo, W. S. F. Wong, N. C. L. Cheng, and X. Zhan, \u201cPolycystic ovarian syndrome in adolescence,\u201d https:\/\/doi.org\/10.1080\/09513590903015551 2009 25 10:634\u2013639 https:\/\/doi.org\/10.1080\/09513590903015551.","DOI":"10.1080\/09513590903015551 10.1080\/09513590903015551"},{"issue":"1","key":"2625_CR8","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/J.JPAG.2010.06.003","volume":"24","author":"J Bronstein","year":"2011","unstructured":"Bronstein J, Tawdekar S, Liu Y, Pawelczak M, David R, Shah B. Age of onset of polycystic ovarian syndrome in girls may be earlier than previously thought. J Pediatr Adolesc Gynecol. 2011;24(1):15\u201320. https:\/\/doi.org\/10.1016\/J.JPAG.2010.06.003.","journal-title":"J Pediatr Adolesc Gynecol"},{"key":"2625_CR9","doi-asserted-by":"publisher","unstructured":"S. Balaji et al., \u201cUrban rural comparisons of polycystic ovary syndrome burden among adolescent girls in a hospital setting in India,\u201d BioMed Research International 2015 https:\/\/doi.org\/10.1155\/2015\/158951","DOI":"10.1155\/2015\/158951"},{"issue":"2","key":"2625_CR10","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/J.FERTNSTERT.2014.11.015","volume":"103","author":"DA Dumesic","year":"2015","unstructured":"Dumesic DA, Meldrum DR, Katz-Jaffe MG, Krisher RL, Schoolcraft WB. Oocyte environment: follicular fluid and cumulus cells are critical for oocyte health. Fertil Steril. 2015;103(2):303\u201316. https:\/\/doi.org\/10.1016\/J.FERTNSTERT.2014.11.015.","journal-title":"Fertil Steril"},{"issue":"2","key":"2625_CR11","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1007\/S10815-020-02014-Y\/TABLES\/5","volume":"38","author":"Y Liu","year":"2021","unstructured":"Liu Y, et al. Oxidative stress markers in the follicular fluid of patients with polycystic ovary syndrome correlate with a decrease in embryo quality. J Assist Reprod Genet. 2021;38(2):471\u20137. https:\/\/doi.org\/10.1007\/S10815-020-02014-Y\/TABLES\/5.","journal-title":"J Assist Reprod Genet"},{"key":"2625_CR12","doi-asserted-by":"publisher","unstructured":"Y. Dincer, T. Akcay, T. Erdem, E. Ilker Saygili, and S. Gundogdu, \u201cDNA damage, DNA susceptibility to oxidation and glutathione level in women with polycystic ovary syndrome,\u201d 65 8:721\u2013728 2009 https:\/\/doi.org\/10.1080\/00365510500375263","DOI":"10.1080\/00365510500375263"},{"key":"2625_CR13","doi-asserted-by":"publisher","unstructured":"K. Polak, A. Czyzyk, T. Simoncini, and B. Meczekalski, \u201cNew markers of insulin resistance in polycystic ovary syndrome,\u201d J Endocrinol Investi 2016 https:\/\/doi.org\/10.1007\/S40618-016-0523-8","DOI":"10.1007\/S40618-016-0523-8"},{"issue":"4","key":"2625_CR14","doi-asserted-by":"publisher","first-page":"e92995","DOI":"10.1371\/JOURNAL.PONE.0092995","volume":"9","author":"M Manco","year":"2014","unstructured":"Manco M, et al. Insulin dynamics in young women with polycystic ovary syndrome and normal glucose tolerance across categories of body mass index. PLoS ONE. 2014;9(4):e92995. https:\/\/doi.org\/10.1371\/JOURNAL.PONE.0092995.","journal-title":"PLoS ONE"},{"issue":"6","key":"2625_CR15","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1093\/HUMREP\/16.6.1255","volume":"16","author":"S Kirchengast","year":"2001","unstructured":"Kirchengast S, Huber J. Body composition characteristics and body fat distribution in lean women with polycystic ovary syndrome. Hum Reprod. 2001;16(6):1255\u201360. https:\/\/doi.org\/10.1093\/HUMREP\/16.6.1255.","journal-title":"Hum Reprod"},{"issue":"3","key":"2625_CR16","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1093\/HUMUPD\/DMS059","volume":"19","author":"M Murri","year":"2013","unstructured":"Murri M, Luque-ram\u00edrez M, Insenser M, Ojeda-ojeda M, Escobar-morreale HF. Circulating markers of oxidative stress and polycystic ovary syndrome (PCOS): a systematic review and meta-analysis. Hum Reprod Update. 2013;19(3):268\u201388. https:\/\/doi.org\/10.1093\/HUMUPD\/DMS059.","journal-title":"Hum Reprod Update"},{"issue":"2","key":"2625_CR17","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/J.BEEM.2006.02.005","volume":"20","author":"MO Goodarzi","year":"2006","unstructured":"Goodarzi MO, Azziz R. Diagnosis, epidemiology, and genetics of the polycystic ovary syndrome. Best Pract Res Clin Endocrinol Metab. 2006;20(2):193\u2013205. https:\/\/doi.org\/10.1016\/J.BEEM.2006.02.005.","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"2625_CR18","doi-asserted-by":"publisher","unstructured":"B. C. J. M. Fauser et al., \u201cConsensus on women\u2019s health aspects of polycystic ovary syndrome (PCOS): the Amsterdam ESHRE\/ASRM-Sponsored 3rd PCOS Consensus Workshop Group,\u201d Fertil Steril,97 1 2012, https:\/\/doi.org\/10.1016\/J.FERTNSTERT.2011.09.024.","DOI":"10.1016\/J.FERTNSTERT.2011.09.024"},{"issue":"2","key":"2625_CR19","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1016\/J.FERTNSTERT.2008.06.035","volume":"91","author":"R Azziz","year":"2009","unstructured":"Azziz R, et al. The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report. Fertil Steril. 2009;91(2):456\u201388. https:\/\/doi.org\/10.1016\/J.FERTNSTERT.2008.06.035.","journal-title":"Fertil Steril"},{"key":"2625_CR20","doi-asserted-by":"crossref","unstructured":"G. Conway, \u2026 D. D.-E. journal of, and undefined 2014, \u201cThe polycystic ovary syndrome: a position statement from the European Society of Endocrinology,\u201d eje.bioscientifica.com, Accessed: Aug. 20, 2022. [Online]. Available: https:\/\/eje.bioscientifica.com\/view\/journals\/eje\/171\/4\/P1.xml","DOI":"10.1530\/EJE-14-0253"},{"key":"2625_CR21","doi-asserted-by":"crossref","unstructured":"R. Legro, S. Arslanian, \u2026 D. E.-T. J. of, and undefined 2013, \u201cDiagnosis and treatment of polycystic ovary syndrome: an Endocrine Society clinical practice guideline,\u201d academic.oup.com, Accessed: Aug. 20, 2022. [Online]. Available: https:\/\/academic.oup.com\/jcem\/article-abstract\/98\/12\/4565\/2833703","DOI":"10.1210\/jc.2013-2350"},{"key":"2625_CR22","unstructured":"\u201cNational Institute of Health (NIH)-Evidence based... - Google Scholar.\u201d https:\/\/scholar.google.co.in\/scholar?hl=en&as_sdt=0%2C5&q=National+Institute+of+Health+%28NIH%29-Evidence+based+workshop+on+Polycystic+Ovary+Syndrome+%282012%29&btnG= (accessed Aug. 20, 2022)."},{"issue":"1","key":"2625_CR23","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/S0015-0282(00)01662-9","volume":"75","author":"MD Kahsar-Miller","year":"2001","unstructured":"Kahsar-Miller MD, Nixon C, Boots LR, Go RC, Azziz R. Prevalence of polycystic ovary syndrome (PCOS) in first-degree relatives of patients with PCOS. Fertil Steril. 2001;75(1):53\u20138. https:\/\/doi.org\/10.1016\/S0015-0282(00)01662-9.","journal-title":"Fertil Steril"},{"key":"2625_CR24","doi-asserted-by":"crossref","unstructured":"R. S. Legro, D. Driscoll, J. F. Strauss, J. Fox, and A. Dunaif, \u201cEvidence for a genetic basis for hyperandrogenemia in polycystic ovary syndrome,\u201d Proceedings of the National Academy of Sciences, 95, 25, 1998.","DOI":"10.1073\/pnas.95.25.14956"},{"key":"2625_CR25","doi-asserted-by":"publisher","first-page":"100060","DOI":"10.1016\/J.EUROX.2019.100060","volume":"3","author":"N Ajmal","year":"2019","unstructured":"Ajmal N, Khan SZ, Shaikh R. Polycystic ovary syndrome (PCOS) and genetic predisposition: a review article. Eur J Obstet Gynecol Reproduct Biol. 2019;3:100060. https:\/\/doi.org\/10.1016\/J.EUROX.2019.100060.","journal-title":"Eur J Obstet Gynecol Reproduct Biol"},{"issue":"9","key":"2625_CR26","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1590\/1806-9282.62.09.867","volume":"62","author":"VHL de Andrade","year":"2016","unstructured":"de Andrade VHL, et al. Current aspects of polycystic ovary syndrome: a literature review. Rev Assoc Med Bras. 2016;62(9):867\u201371. https:\/\/doi.org\/10.1590\/1806-9282.62.09.867.","journal-title":"Rev Assoc Med Bras"},{"key":"2625_CR27","doi-asserted-by":"crossref","unstructured":"V. Nelson-Degrave, \u2026 J. W.-M., and undefined 2005, \u201cAlterations in mitogen-activated protein kinase kinase and extracellular regulated kinase signaling in theca cells contribute to excessive androgen production in,\u201d academic.oup.com, Accessed: Aug. 20, 2022. [Online]. Available: https:\/\/academic.oup.com\/mend\/article-abstract\/19\/2\/379\/2741316","DOI":"10.1210\/me.2004-0178"},{"issue":"1","key":"2625_CR28","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1210\/JCEM.81.1.8550768","volume":"81","author":"D Willis","year":"1996","unstructured":"Willis D, Mason H, Gilling-Smith C, Franks S. Modulation by insulin of follicle-stimulating hormone and luteinizing hormone actions in human granulosa cells of normal and polycystic ovaries. J Clin Endocrinol Metab. 1996;81(1):302\u20139. https:\/\/doi.org\/10.1210\/JCEM.81.1.8550768.","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2625_CR29","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1159\/000098956","volume":"64","author":"BB da Silva","year":"2007","unstructured":"da Silva BB, et al. Morphological and morphometric analysis of the adrenal cortex of androgenized female rats. Gynecol Obstet Invest. 2007;64(1):44\u20138. https:\/\/doi.org\/10.1159\/000098956.","journal-title":"Gynecol Obstet Invest"},{"key":"2625_CR30","doi-asserted-by":"publisher","unstructured":"A. Dunaif and C. B. Book, \u201cInsulin resistance in the polycystic ovary syndrome,\u201d Clinical Research in Diabetes and Obesity, 249\u2013274, 1997, https:\/\/doi.org\/10.1007\/978-1-4757-3906-0_14.","DOI":"10.1007\/978-1-4757-3906-0_14"},{"key":"2625_CR31","unstructured":"R. Dumitrescu, C. Mehedintu, I. Briceag, V. L. Purcarea, and D. Hudita, \u201cThe polycystic ovary syndrome: an update on metabolic and hormonal mechanisms,\u201d Journal of Medicine and Life, vol. 8, no. 2, p. 142, Apr. 2015, Accessed: Jan. 20, 2022. [Online]. Available: \/pmc\/articles\/PMC4392092\/"},{"issue":"2","key":"2625_CR32","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1080\/09513590.2019.1633296","volume":"36","author":"S Chun","year":"2020","unstructured":"Chun S. Relationship between early follicular serum estrone level and other hormonal or ultrasonographic parameters in women with polycystic ovary syndrome. Gynecol Endocrinol. 2020;36(2):143\u20137. https:\/\/doi.org\/10.1080\/09513590.2019.1633296.","journal-title":"Gynecol Endocrinol"},{"issue":"4","key":"2625_CR33","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1016\/0002-9378(75)90081-2","volume":"121","author":"GW DeVane","year":"1975","unstructured":"DeVane GW, Czekala NM, Judd HL, Yen SSC. Circulating gonadotropins, estrogens, and androgens in polycystic ovarian disease. Am J Obstet Gynecol. 1975;121(4):496\u2013500. https:\/\/doi.org\/10.1016\/0002-9378(75)90081-2.","journal-title":"Am J Obstet Gynecol"},{"key":"2625_CR34","doi-asserted-by":"publisher","unstructured":"E. Doh et al., \u201cThe relationship between adiposity and insulin sensitivity in african women living with the polycystic ovarian syndrome: a clamp study,\u201d International Journal of Endocrinology, vol. 2016, https:\/\/doi.org\/10.1155\/2016\/9201701.","DOI":"10.1155\/2016\/9201701"},{"key":"2625_CR35","doi-asserted-by":"publisher","unstructured":"R. Pasquali and A. Gambineri, \u201cNew perspectives on the definition and management of polycystic ovary syndrome,\u201d Journal of Endocrinological Investigation 2018 41:10, vol. 41 10:1123\u20131135, 2018, https:\/\/doi.org\/10.1007\/S40618-018-0832-1.","DOI":"10.1007\/S40618-018-0832-1"},{"issue":"4","key":"2625_CR36","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/S0015-0282(02)02985-0","volume":"77","author":"HG Burger","year":"2002","unstructured":"Burger HG. Androgen production in women. Fertil Steril. 2002;77(4):3\u20135. https:\/\/doi.org\/10.1016\/S0015-0282(02)02985-0.","journal-title":"Fertil Steril"},{"issue":"3","key":"2625_CR37","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/S0022-3476(83)80678-7","volume":"102","author":"GW Moll","year":"1983","unstructured":"Moll GW, Rosenfield RL. Plasma free testosterone in the diagnosis of adolescent polycystic ovary syndrome. J Pediatr. 1983;102(3):461\u20134. https:\/\/doi.org\/10.1016\/S0022-3476(83)80678-7.","journal-title":"J Pediatr"},{"issue":"1","key":"2625_CR38","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/S0015-0282(00)00584-7","volume":"74","author":"MHA van Hooff","year":"2000","unstructured":"van Hooff MHA, Voorhorst FJ, Kaptein MBH, Hirasing RA, Koppenaal C, Schoemaker J. Polycystic ovaries in adolescents and the relationship with menstrual cycle patterns, luteinizing hormone, androgens, and insulin. Fertil Steril. 2000;74(1):49\u201358. https:\/\/doi.org\/10.1016\/S0015-0282(00)00584-7.","journal-title":"Fertil Steril"},{"issue":"5","key":"2625_CR39","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1210\/ER.2015-1104","volume":"37","author":"RL Rosenfield","year":"2016","unstructured":"Rosenfield RL, Ehrmann DA. The pathogenesis of polycystic ovary syndrome (PCOS): the hypothesis of PCOS as functional ovarian hyperandrogenism revisited. Endocr Rev. 2016;37(5):467\u2013520. https:\/\/doi.org\/10.1210\/ER.2015-1104.","journal-title":"Endocr Rev"},{"key":"2625_CR40","doi-asserted-by":"publisher","first-page":"100085","DOI":"10.1016\/J.ENDMTS.2021.100085","volume":"3","author":"J Bulsara","year":"2021","unstructured":"Bulsara J, Patel P, Soni A, Acharya S. A review: brief insight into polycystic ovarian syndrome. Endocr Metab Sci. 2021;3:100085. https:\/\/doi.org\/10.1016\/J.ENDMTS.2021.100085.","journal-title":"Endocr Metab Sci"},{"key":"2625_CR41","doi-asserted-by":"publisher","unstructured":"D. E. Moller and J. S. Flier, \u201cDetection of an alteration in the insulin-receptor gene in a patient with insulin resistance, Acanthosis nigricans, and the polycystic ovary syndrome (type A insulin resistance),\u201d 319, 23:1526\u20131529 2010, https:\/\/doi.org\/10.1056\/NEJM198812083192306.","DOI":"10.1056\/NEJM198812083192306"},{"key":"2625_CR42","doi-asserted-by":"publisher","unstructured":"S. Toosy, R. Sodi, and J. M. Pappachan, \u201cLean polycystic ovary syndrome (PCOS): an evidence-based practical approach,\u201d Journal of Diabetes & Metabolic Disorders 2018 17:2 277\u2013285 2018 https:\/\/doi.org\/10.1007\/S40200-018-0371-5.","DOI":"10.1007\/S40200-018-0371-5"},{"key":"2625_CR43","doi-asserted-by":"publisher","first-page":"516","DOI":"10.3389\/FENDO.2020.00516","volume":"11","author":"A Aversa","year":"2020","unstructured":"Aversa A, et al. Fundamental concepts and novel aspects of polycystic ovarian syndrome: expert consensus resolutions. Front Endocrinol. 2020;11:516. https:\/\/doi.org\/10.3389\/FENDO.2020.00516.","journal-title":"Front Endocrinol"},{"issue":"6","key":"2625_CR44","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1203\/01.pdr.0000246097.73031.27","volume":"60","author":"TS Hannon","year":"2006","unstructured":"Hannon TS, Janosky J, Arslanian SA. longitudinal study of physiologic insulin resistance and metabolic changes of puberty. Pediatric Research. 2006;60(6):759\u201363. https:\/\/doi.org\/10.1203\/01.pdr.0000246097.73031.27.","journal-title":"Pediatric Research."},{"issue":"433","key":"2625_CR45","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1111\/J.1651-2227.1999.TB14410.X","volume":"88","author":"S Caprio","year":"1999","unstructured":"Caprio S. Insulin: the other anabolic hormone of puberty. Acta P\u00e6diatrica. 1999;88(433):84\u20137. https:\/\/doi.org\/10.1111\/J.1651-2227.1999.TB14410.X.","journal-title":"Acta P\u00e6diatrica"},{"issue":"2","key":"2625_CR46","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1111\/J.1463-1326.2005.00496.X","volume":"8","author":"LE Fridlyand","year":"2006","unstructured":"Fridlyand LE, Philipson LH. Reactive species and early manifestation of insulin resistance in type 2 diabetes. Diabetes Obes Metab. 2006;8(2):136\u201345. https:\/\/doi.org\/10.1111\/J.1463-1326.2005.00496.X.","journal-title":"Diabetes Obes Metab"},{"issue":"4","key":"2625_CR47","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1093\/HUMREP\/DEL466","volume":"22","author":"KM Seow","year":"2007","unstructured":"Seow KM, Juan CC, Hsu YP, Hwang JL, Huang LW, Ho LT. Amelioration of insulin resistance in women with PCOS via reduced insulin receptor substrate-1 Ser312 phosphorylation following laparoscopic ovarian electrocautery. Hum Reprod. 2007;22(4):1003\u201310. https:\/\/doi.org\/10.1093\/HUMREP\/DEL466.","journal-title":"Hum Reprod"},{"issue":"5","key":"2625_CR48","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1152\/AJPENDO.00361.2004\/ASSET\/IMAGES\/LARGE\/ZH10050520890006.JPEG","volume":"288","author":"A Corbould","year":"2005","unstructured":"Corbould A, et al. Insulin resistance in the skeletal muscle of women with PCOS involves intrinsic and acquired defects in insulin signaling. Am J Physiol Endocrinol Metab. 2005;288(5):51\u20135. https:\/\/doi.org\/10.1152\/AJPENDO.00361.2004\/ASSET\/IMAGES\/LARGE\/ZH10050520890006.JPEG.","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"4","key":"2625_CR49","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1016\/J.FERTNSTERT.2014.06.027","volume":"102","author":"L Chen","year":"2014","unstructured":"Chen L, Xu WM, Zhang D. Association of abdominal obesity, insulin resistance, and oxidative stress in adipose tissue in women with polycystic ovary syndrome. Fertil Steril. 2014;102(4):1167-1174.e4. https:\/\/doi.org\/10.1016\/J.FERTNSTERT.2014.06.027.","journal-title":"Fertil Steril"},{"key":"2625_CR50","doi-asserted-by":"publisher","unstructured":"J. L. Evans, B. A. Maddux, and I. D. Goldfine, \u201cThe molecular basis for oxidative stress-induced insulin resistance,\u201d https:\/\/home.liebertpub.com\/ars, 7, 7\u20138:1040\u20131052, 2005, https:\/\/doi.org\/10.1089\/ARS.2005.7.1040.","DOI":"10.1089\/ARS.2005.7.1040"},{"issue":"1","key":"2625_CR51","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1210\/JC.2005-1696","volume":"91","author":"F Gonz\u00e1lez","year":"2006","unstructured":"Gonz\u00e1lez F, Rote NS, Minium J, Kirwan JP. reactive oxygen species-induced oxidative stress in the development of insulin resistance and hyperandrogenism in polycystic ovary syndrome. J Clin Endocrinol Metab. 2006;91(1):336\u201340. https:\/\/doi.org\/10.1210\/JC.2005-1696.","journal-title":"J Clin Endocrinol Metab"},{"key":"2625_CR52","doi-asserted-by":"publisher","unstructured":"V. M. Victor, M. Rocha, E. Sola, C. Banuls, K. Garcia-Malpartida, and A. Hernandez- Mijares, \u201cOxidative stress, endothelial dysfunction and atherosclerosis,\u201d Current Pharmaceutical Design, 15, 26:2988\u20133002, 2009, https:\/\/doi.org\/10.2174\/138161209789058093","DOI":"10.2174\/138161209789058093"},{"issue":"5","key":"2625_CR53","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/S0009-9120(01)00245-4","volume":"34","author":"T Sabuncu","year":"2001","unstructured":"Sabuncu T, Vural H, Harma M, Harma M. Oxidative stress in polycystic ovary syndrome and its contribution to the risk of cardiovascular disease\u2606. Clin Biochem. 2001;34(5):407\u201313. https:\/\/doi.org\/10.1016\/S0009-9120(01)00245-4.","journal-title":"Clin Biochem"},{"issue":"1\u20132","key":"2625_CR54","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/J.MRFMMM.2011.02.015","volume":"711","author":"D Ziech","year":"2011","unstructured":"Ziech D, Franco R, Pappa A, Panayiotidis MI. Reactive oxygen species (ROS)\u2013\u2013induced genetic and epigenetic alterations in human carcinogenesis. Mutat Res\/Fundam Mol Mechan Mutagen. 2011;711(1\u20132):167\u201373. https:\/\/doi.org\/10.1016\/J.MRFMMM.2011.02.015.","journal-title":"Mutat Res\/Fundam Mol Mechan Mutagen"},{"key":"2625_CR55","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2010\/302051","volume":"2010","author":"KV Donkena","year":"2010","unstructured":"Donkena KV, Young CYF, Tindall DJ. oxidative stress and dna methylation in prostate cancer. Obstet Gynecol Int. 2010;2010:1\u201314. https:\/\/doi.org\/10.1155\/2010\/302051.","journal-title":"Obstet Gynecol Int"},{"issue":"1","key":"2625_CR56","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/J.CANLET.2008.02.026","volume":"266","author":"R Franco","year":"2008","unstructured":"Franco R, Schoneveld O, Georgakilas AG, Panayiotidis MI. Oxidative stress, DNA methylation and carcinogenesis. Cancer Lett. 2008;266(1):6\u201311. https:\/\/doi.org\/10.1016\/J.CANLET.2008.02.026.","journal-title":"Cancer Lett"},{"issue":"2","key":"2625_CR57","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1093\/HUMREP\/DEP399","volume":"25","author":"WA March","year":"2010","unstructured":"March WA, Moore VM, Willson KJ, Phillips DIW, Norman RJ, Davies MJ. The prevalence of polycystic ovary syndrome in a community sample assessed under contrasting diagnostic criteria. Hum Reprod. 2010;25(2):544\u201351. https:\/\/doi.org\/10.1093\/HUMREP\/DEP399.","journal-title":"Hum Reprod"},{"key":"2625_CR58","doi-asserted-by":"publisher","unstructured":"T. Zuo, M. Zhu, and W. Xu, \u201cRoles of oxidative stress in polycystic ovary syndrome and cancers,\u201d Oxidative Medicine and Cellular Longevity, vol. 2016, 2016, https:\/\/doi.org\/10.1155\/2016\/8589318.","DOI":"10.1155\/2016\/8589318"},{"issue":"8","key":"2625_CR59","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1016\/S0009-9120(02)00363-6","volume":"35","author":"M Ozata","year":"2002","unstructured":"Ozata M, et al. Increased oxidative stress and hypozincemia in male obesity. Clin Biochem. 2002;35(8):627\u201331. https:\/\/doi.org\/10.1016\/S0009-9120(02)00363-6.","journal-title":"Clin Biochem"},{"issue":"12","key":"2625_CR60","doi-asserted-by":"publisher","first-page":"6454","DOI":"10.1210\/JC.2004-2438","volume":"90","author":"C Couillard","year":"2005","unstructured":"Couillard C, et al. Circulating levels of oxidative stress markers and endothelial adhesion molecules in men with abdominal obesity. J Clin Endocrinol Metab. 2005;90(12):6454\u20139. https:\/\/doi.org\/10.1210\/JC.2004-2438.","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"2625_CR61","doi-asserted-by":"publisher","first-page":"3760","DOI":"10.1039\/C5FO00612K","volume":"6","author":"Y Hu","year":"2015","unstructured":"Hu Y, Zhao Y, Ren D, Guo J, Luo Y, Yang X. Hypoglycemic and hepatoprotective effects of d - chiro -inositol-enriched tartary buckwheat extract in high fructose-fed mice. Food Funct. 2015;6(12):3760\u20139. https:\/\/doi.org\/10.1039\/C5FO00612K.","journal-title":"Food Funct"},{"key":"2625_CR62","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/J.LFS.2015.07.010","volume":"137","author":"MC Castro","year":"2015","unstructured":"Castro MC, Massa ML, Arbel\u00e1ez LG, Schinella G, Gagliardino JJ, Francini F. Fructose-induced inflammation, insulin resistance and oxidative stress: a liver pathological triad effectively disrupted by lipoic acid. Life Sci. 2015;137:1\u20136. https:\/\/doi.org\/10.1016\/J.LFS.2015.07.010.","journal-title":"Life Sci"},{"issue":"1","key":"2625_CR63","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/J.MCE.2010.08.002","volume":"335","author":"A Repaci","year":"2011","unstructured":"Repaci A, Gambineri A, Pasquali R. The role of low-grade inflammation in the polycystic ovary syndrome. Mol Cell Endocrinol. 2011;335(1):30\u201341. https:\/\/doi.org\/10.1016\/J.MCE.2010.08.002.","journal-title":"Mol Cell Endocrinol"},{"issue":"7","key":"2625_CR64","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1016\/J.METABOL.2009.02.022","volume":"58","author":"F Gonz\u00e1lez","year":"2009","unstructured":"Gonz\u00e1lez F, Rote NS, Minium J, Kirwan JP. Evidence of proatherogenic inflammation in polycystic ovary syndrome. Metab. 2009;58(7):954\u201362. https:\/\/doi.org\/10.1016\/J.METABOL.2009.02.022.","journal-title":"Metab"},{"issue":"12","key":"2625_CR65","doi-asserted-by":"publisher","first-page":"3333","DOI":"10.1093\/HUMREP\/DEI258","volume":"20","author":"M Yilmaz","year":"2005","unstructured":"Yilmaz M, et al. The effects of rosiglitazone and metformin on oxidative stress and homocysteine levels in lean patients with polycystic ovary syndrome. Hum Reprod. 2005;20(12):3333\u201340. https:\/\/doi.org\/10.1093\/HUMREP\/DEI258.","journal-title":"Hum Reprod"},{"key":"2625_CR66","doi-asserted-by":"publisher","first-page":"S7","DOI":"10.1016\/J.FERTNSTERT.2005.07.016","volume":"84","author":"PC Piotrowski","year":"2005","unstructured":"Piotrowski PC, et al. Antioxidants inhibit expression of genes involved in testosterone production by theca-interstitial cells. Fertil Steril. 2005;84:S7. https:\/\/doi.org\/10.1016\/J.FERTNSTERT.2005.07.016.","journal-title":"Fertil Steril"},{"issue":"3","key":"2625_CR67","doi-asserted-by":"publisher","first-page":"270","DOI":"10.2174\/138161212799040457","volume":"18","author":"E Diamanti-Kandarakis","year":"2012","unstructured":"Diamanti-Kandarakis E, Christakou C, Marinakis E. Phenotypes and enviromental factors: their influence in PCOS. Curr Pharm Des. 2012;18(3):270\u201382. https:\/\/doi.org\/10.2174\/138161212799040457.","journal-title":"Curr Pharm Des"},{"issue":"7","key":"2625_CR68","doi-asserted-by":"publisher","first-page":"2231","DOI":"10.1210\/JC.2011-3408","volume":"97","author":"C Piperi","year":"2012","unstructured":"Piperi C, Adamopoulos C, Dalagiorgou G, Diamanti-Kandarakis E, Papavassiliou AG. Crosstalk between advanced glycation and endoplasmic reticulum stress: emerging therapeutic targeting for metabolic Diseases. J Clin Endocrinol Metab. 2012;97(7):2231\u201342. https:\/\/doi.org\/10.1210\/JC.2011-3408.","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"2625_CR69","doi-asserted-by":"publisher","first-page":"10129","DOI":"10.3390\/NU7125524","volume":"7","author":"D Garg","year":"2015","unstructured":"Garg D, Merhi Z. Advanced glycation end products: link between diet and ovulatory dysfunction in PCOS? Nutrients. 2015;7(12):10129\u201344. https:\/\/doi.org\/10.3390\/NU7125524.","journal-title":"Nutrients"},{"key":"2625_CR70","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1007\/s00418-006-0265-3","volume":"127","author":"E Diamanti-Kandarakis","year":"2007","unstructured":"Diamanti-Kandarakis E, et al. Immunohistochemical localization of advanced glycation end-products (AGEs) and their receptor (RAGE) in polycystic and normal ovaries. Histochem Cell Biol. 2007;127:581\u20139. https:\/\/doi.org\/10.1007\/s00418-006-0265-3.","journal-title":"Histochem Cell Biol"},{"issue":"1","key":"2625_CR71","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/J.ATHEROSCLEROSIS.2007.07.025","volume":"196","author":"G Basta","year":"2008","unstructured":"Basta G. Receptor for advanced glycation endproducts and atherosclerosis: from basic mechanisms to clinical implications. Atherosclerosis. 2008;196(1):9\u201321. https:\/\/doi.org\/10.1016\/J.ATHEROSCLEROSIS.2007.07.025.","journal-title":"Atherosclerosis"},{"issue":"1","key":"2625_CR72","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1007\/BF03401321","volume":"13","author":"E Tantalaki","year":"2014","unstructured":"Tantalaki E, et al. Impact of dietary modification of advanced glycation end products (AGEs) on the hormonal and metabolic profile of women with polycystic ovary syndrome (PCOS). Hormones. 2014;13(1):65\u201373. https:\/\/doi.org\/10.1007\/BF03401321.","journal-title":"Hormones"},{"issue":"1","key":"2625_CR73","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1111\/J.1365-2265.2004.02170.X","volume":"62","author":"E Diamanti-Kandarakis","year":"2005","unstructured":"Diamanti-Kandarakis E, Piperi C, Kalofoutis A, Creatsas G. Increased levels of serum advanced glycation end-products in women with polycystic ovary syndrome. Clin Endocrinol. 2005;62(1):37\u201343. https:\/\/doi.org\/10.1111\/J.1365-2265.2004.02170.X.","journal-title":"Clin Endocrinol"},{"issue":"24","key":"2625_CR74","doi-asserted-by":"publisher","first-page":"15596","DOI":"10.1073\/PNAS.242407999","volume":"99","author":"H Vlassara","year":"2002","unstructured":"Vlassara H, et al. Inflammatory mediators are induced by dietary glycotoxins, a major risk factor for diabetic angiopathy. Proc Natl Acad Sci. 2002;99(24):15596\u2013601. https:\/\/doi.org\/10.1073\/PNAS.242407999.","journal-title":"Proc Natl Acad Sci"},{"issue":"4","key":"2625_CR75","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1093\/GERONA\/62.4.427","volume":"62","author":"J Uribarri","year":"2007","unstructured":"Uribarri J, et al. Circulating glycotoxins and dietary advanced glycation endproducts: two links to inflammatory response, oxidative stress, and aging. J Gerontol Series A. 2007;62(4):427\u201333. https:\/\/doi.org\/10.1093\/GERONA\/62.4.427.","journal-title":"J Gerontol Series A"},{"issue":"7","key":"2625_CR76","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1007\/BF03402014\/FIGURES\/5","volume":"8","author":"W Cai","year":"2002","unstructured":"Cai W, di Gao Q, Zhu L, Peppa M, He C, Vlassara H. Oxidative stress-inducing carbonyl compounds from common foods: novel mediators of cellular dysfunction. Mol Med. 2002;8(7):337\u201346. https:\/\/doi.org\/10.1007\/BF03402014\/FIGURES\/5.","journal-title":"Mol Med"},{"issue":"2","key":"2625_CR77","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1042\/BST20140023","volume":"42","author":"C Tatone","year":"2014","unstructured":"Tatone C, Eichenlaub-Ritter U, Amicarelli F. Dicarbonyl stress and glyoxalases in ovarian function. Biochem Soc Trans. 2014;42(2):433\u20138. https:\/\/doi.org\/10.1042\/BST20140023.","journal-title":"Biochem Soc Trans"},{"issue":"10","key":"2625_CR78","doi-asserted-by":"publisher","first-page":"987","DOI":"10.2174\/138161208784139747","volume":"14","author":"H Unoki","year":"2008","unstructured":"Unoki H, Yamagishi S. Advanced glycation end products and insulin resistance. Curr Pharm Des. 2008;14(10):987\u20139. https:\/\/doi.org\/10.2174\/138161208784139747.","journal-title":"Curr Pharm Des"},{"issue":"1","key":"2625_CR79","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1093\/HUMREP\/DET383","volume":"29","author":"Z Merhi","year":"2014","unstructured":"Merhi Z. Advanced glycation end products and their relevance in female reproduction. Hum Reprod. 2014;29(1):135\u201345. https:\/\/doi.org\/10.1093\/HUMREP\/DET383.","journal-title":"Hum Reprod"},{"issue":"12","key":"2625_CR80","doi-asserted-by":"publisher","first-page":"2587","DOI":"10.1161\/01.ATV.0000190660.32863.cd","volume":"25","author":"H Koyama","year":"2005","unstructured":"Koyama H, et al. Plasma level of endogenous secretory RAGE is associated with components of the metabolic syndrome and atherosclerosis. Arterioscler Thromb Vasc Biol. 2005;25(12):2587\u201393. https:\/\/doi.org\/10.1161\/01.ATV.0000190660.32863.cd.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"2","key":"2625_CR81","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1016\/J.ATHEROSCLEROSIS.2010.04.006","volume":"211","author":"H Ueno","year":"2010","unstructured":"Ueno H, et al. Receptor for advanced glycation end-products (RAGE) regulation of adiposity and adiponectin is associated with atherogenesis in apoE-deficient mouse. Atherosclerosis. 2010;211(2):431\u20136. https:\/\/doi.org\/10.1016\/J.ATHEROSCLEROSIS.2010.04.006.","journal-title":"Atherosclerosis"},{"key":"2625_CR82","doi-asserted-by":"crossref","unstructured":"P. Pigny, S. Jonard, \u2026 Y. R.-T. J. of C., and undefined 2006, \u201cSerum anti-Mullerian hormone as a surrogate for antral follicle count for definition of the polycystic ovary syndrome,\u201d academic.oup.com, Accessed: Aug. 20, 2022. [Online]. Available: https:\/\/academic.oup.com\/jcem\/article-abstract\/91\/3\/941\/2843410","DOI":"10.1210\/jc.2005-2076"},{"key":"2625_CR83","unstructured":"C. Cook, Y. Siow, A. Brenner, M. F.-F. and sterility, and undefined 2002, \u201cRelationship between serum m\u00fcllerian-inhibiting substance and other reproductive hormones in untreated women with polycystic ovary syndrome and normal,\u201d Elsevier, Accessed: Aug. 20, 2022. [Online]. Available: https:\/\/www.sciencedirect.com\/science\/article\/pii\/S0015028201029442?casa_token=3ObG0fuGhhUAAAAA:ffl0nsmfH5O14HW73cx-pjnR6AKND3wtBrE_Fem1J7RWz111t5uJqetqOOB7b23MjfNEsY7PeQ38"},{"key":"2625_CR84","doi-asserted-by":"crossref","unstructured":"L. Pellatt, L. Hanna, M. Brincat, \u2026 R. G.-T. J. of, and undefined 2007, \u201cGranulosa cell production of anti-Mullerian hormone is increased in polycystic ovaries,\u201d academic.oup.com, Accessed: Aug. 20, 2022. [Online]. Available: https:\/\/academic.oup.com\/jcem\/article-abstract\/92\/1\/240\/2598594","DOI":"10.1210\/jc.2006-1582"},{"issue":"12","key":"2625_CR85","doi-asserted-by":"publisher","first-page":"5957","DOI":"10.1210\/JC.2003-030727","volume":"88","author":"P Pigny","year":"2003","unstructured":"Pigny P, et al. Elevated serum level of anti-mullerian hormone in patients with polycystic ovary syndrome: relationship to the ovarian follicle excess and to the follicular arrest. J Clin Endocrinol Metab. 2003;88(12):5957\u201362. https:\/\/doi.org\/10.1210\/JC.2003-030727.","journal-title":"J Clin Endocrinol Metab"},{"key":"2625_CR86","unstructured":"M. Goodarzi, D. Dumesic, \u2026 G. C.-N. reviews, and undefined 2011, \u201cPolycystic ovary syndrome: etiology, pathogenesis and diagnosis,\u201d nature.com, Accessed: Aug. 21, 2022. [Online]. Available: https:\/\/www.nature.com\/articles\/nrendo.2010.217"},{"issue":"6","key":"2625_CR87","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1038\/S41591-018-0035-5","volume":"24","author":"B Tata","year":"2018","unstructured":"Tata B, et al. Elevated prenatal anti-Mullerian hormone reprograms the fetus and induces polycystic ovary syndrome in adulthood. Nat Med. 2018;24(6):834\u20137. https:\/\/doi.org\/10.1038\/S41591-018-0035-5.","journal-title":"Nat Med"},{"key":"2625_CR88","unstructured":"N. Mimouni, I. Paiva, A. Barbotin, F. T.-C. metabolism, and undefined 2021, \u201cPolycystic ovary syndrome is transmitted via a transgenerational epigenetic process,\u201d Elsevier, Accessed: Aug. 21, 2022. [Online]. Available: https:\/\/www.sciencedirect.com\/science\/article\/pii\/S1550413121000048"},{"key":"2625_CR89","unstructured":"L. Moore, T. Le, G. F.- Neuropsychopharmacology, and undefined 2013, \u201cDNA methylation and its basic function,\u201d nature.com, Accessed: Aug. 21, 2022. [Online]. Available: https:\/\/www.nature.com\/articles\/npp2012112"},{"key":"2625_CR90","unstructured":"R. Tal, D. Seifer, M. Khanimov, \u2026 H. M.-A. journal of, and undefined 2014, \u201cCharacterization of women with elevated antim\u00fcllerian hormone levels (AMH): correlation of AMH with polycystic ovarian syndrome phenotypes and assisted,\u201d Elsevier, Accessed: Aug. 21, 2022. [Online]. Available: https:\/\/www.sciencedirect.com\/science\/article\/pii\/S0002937814001689"},{"key":"2625_CR91","doi-asserted-by":"crossref","unstructured":"R. Homburg, A. Ray, P. Bhide, A. Gudi, A. S.-\u2026 Reproduction, and undefined 2013, \u201cThe relationship of serum anti-Mullerian hormone with polycystic ovarian morphology and polycystic ovary syndrome: a prospective cohort study,\u201d academic.oup.com, Accessed: Aug. 21, 2022. [Online]. Available: https:\/\/academic.oup.com\/humrep\/article-abstract\/28\/4\/1077\/653152","DOI":"10.1093\/humrep\/det015"},{"key":"2625_CR92","unstructured":"Y. Lin et al., \u201cAntim\u00fcllerian hormone and polycystic ovary syndrome,\u201d Elsevier, Accessed: Aug. 21, 2022. [Online]. Available: https:\/\/www.sciencedirect.com\/science\/article\/pii\/S0015028211005863?casa_token=qb4h0HFI1noAAAAA:Od82bVmuVqtLcNfJlQkGjcPuNVgY-Ptj2N6QM2VcyynJt-TcHxkjQgRMD9TB68hJClVDQTr82HY"},{"key":"2625_CR93","doi-asserted-by":"publisher","unstructured":"A. Piouka, D. Farmakiotis, I. Katsikis, D. Macut, S. Gerou, and D. Panidis, \u201cAnti-M\u00fcllerian hormone levels reflect severity of PCOS but are negatively influenced by obesity: Relationship with increased luteinizing hormone levels,\u201d American Journal of Physiology - Endocrinology and Metabolism, 296, 2, 2009, https:\/\/doi.org\/10.1152\/AJPENDO.90684.2008.","DOI":"10.1152\/AJPENDO.90684.2008"},{"issue":"7","key":"2625_CR94","doi-asserted-by":"publisher","first-page":"1814","DOI":"10.1093\/HUMREP\/DEH873","volume":"20","author":"T Eldar-Geva","year":"2005","unstructured":"Eldar-Geva T, et al. Serum anti-Mullerian hormone levels during controlled ovarian hyperstimulation in women with polycystic ovaries with and without hyperandrogenism. Hum Reprod. 2005;20(7):1814\u20139. https:\/\/doi.org\/10.1093\/HUMREP\/DEH873.","journal-title":"Hum Reprod"},{"key":"2625_CR95","doi-asserted-by":"crossref","unstructured":"\u201cElevated serum level of anti-mullerian hormone in patients with polycystic ovary syndrome: relationship to the ovarian follicle excess and to the follicular arrest,\u201d academic.oup.com, Accessed: Aug. 21, 2022. [Online]. Available: https:\/\/academic.oup.com\/jcem\/article-abstract\/88\/12\/5957\/2661509","DOI":"10.1210\/jc.2003-030727"},{"issue":"4","key":"2625_CR96","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1093\/HUMUPD\/DMI013","volume":"11","author":"DH Abbott","year":"2005","unstructured":"Abbott DH, Barnett DK, Bruns CM, Dumesic DA. Androgen excess fetal programming of female reproduction: a developmental aetiology for polycystic ovary syndrome? Hum Reprod Update. 2005;11(4):357\u201374. https:\/\/doi.org\/10.1093\/HUMUPD\/DMI013.","journal-title":"Hum Reprod Update"},{"issue":"6","key":"2625_CR97","doi-asserted-by":"publisher","first-page":"1678","DOI":"10.1111\/1467-8624.00498","volume":"73","author":"M Hines","year":"2002","unstructured":"Hines M, Golombok S, Rust J, Johnston KJ, Golding J. Testosterone during pregnancy and gender role behavior of preschool children: a longitudinal, population study. Child Dev. 2002;73(6):1678\u201387. https:\/\/doi.org\/10.1111\/1467-8624.00498.","journal-title":"Child Dev"},{"key":"2625_CR98","unstructured":"R. Hart, D. Sloboda, D. Doherty, R. N.-F. and sterility, and undefined 2010, \u201cCirculating maternal testosterone concentrations at 18 weeks of gestation predict circulating levels of antim\u00fcllerian hormone in adolescence: a prospective,\u201d Elsevier, Accessed: Aug. 21, 2022. [Online]. Available: https:\/\/www.sciencedirect.com\/science\/article\/pii\/S0015028209043192?casa_token=w61Hv4KIJ3gAAAAA:BrYdCIuHRtNjgg607BUfC_sKuz4L0X7fqWWYQTAKc6h4Yn29mwqO4BQFvA5v-RiyKTtgzQ9TI9Y"},{"issue":"9389","key":"2625_CR99","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1016\/S0140-6736(03)14410-8","volume":"362","author":"LJ Webber","year":"2003","unstructured":"Webber LJ, et al. Formation and early development of follicles in the polycystic ovary. Lancet. 2003;362(9389):1017\u201321. https:\/\/doi.org\/10.1016\/S0140-6736(03)14410-8.","journal-title":"Lancet"},{"issue":"6","key":"2625_CR100","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1111\/J.1365-2265.2012.04443.X","volume":"77","author":"S Palomba","year":"2012","unstructured":"Palomba S, et al. Pervasive developmental disorders in children of hyperandrogenic women with polycystic ovary syndrome: a longitudinal case-control study. Clin Endocrinol. 2012;77(6):898\u2013904. https:\/\/doi.org\/10.1111\/J.1365-2265.2012.04443.X.","journal-title":"Clin Endocrinol"},{"key":"2625_CR101","doi-asserted-by":"publisher","unstructured":"M. Maliqueo, H. E. Lara, F. S\u00e1 nchez, B. rbara Echibur\u00fa, N. Crisosto, and T. Sir-Petermann, \u201cPlacental steroidogenesis in pregnant women with polycystic ovary syndrome,\u201d Elsevier, 2013, https:\/\/doi.org\/10.1016\/j.ejogrb.2012.10.015.","DOI":"10.1016\/j.ejogrb.2012.10.015"},{"key":"2625_CR102","doi-asserted-by":"crossref","unstructured":"E. Kandaraki, \u2026 A. C.-T. J. of, and undefined 2011, \u201cEndocrine disruptors and polycystic ovary syndrome (PCOS): elevated serum levels of bisphenol A in women with PCOS,\u201d academic.oup.com, Accessed: Aug. 21, 2022. [Online]. Available: https:\/\/academic.oup.com\/jcem\/article-abstract\/96\/3\/E480\/2597282","DOI":"10.1210\/jc.2010-1658"},{"key":"2625_CR103","doi-asserted-by":"publisher","unstructured":"L. Akin et al., \u201cThe endocrine disruptor bisphenol A may play a role in the aetiopathogenesis of polycystic ovary syndrome in adolescent girls.,\u201d Acta Paediatrica (Oslo, Norway\u202f: 1992), 104, 4:e171\u20137, 2015, https:\/\/doi.org\/10.1111\/APA.12885","DOI":"10.1111\/APA.12885"},{"key":"2625_CR104","unstructured":"A. Rutkowska, E. D.-K.-F. and sterility, and undefined 2016, \u201cPolycystic ovary syndrome and environmental toxins,\u201d Elsevier, Accessed: Aug. 21, 2022. [Online]. Available: https:\/\/www.sciencedirect.com\/science\/article\/pii\/S0015028216627280"},{"key":"2625_CR105","unstructured":"D. Micic, V. Popovic, M. Nesovic, \u2026 M. S.-J. of steroid, and undefined 1988, \u201cAndrogen levels during sequential insulin euglycemic clamp studies in patients with polycystic ovary disease,\u201d Elsevier, Accessed: Aug. 21, 2022. [Online]. Available: https:\/\/www.sciencedirect.com\/science\/article\/pii\/0022473188903445"},{"key":"2625_CR106","doi-asserted-by":"publisher","unstructured":"A. Dumont, G. Robin, D. D. Endocrinology, D. and, and undefined 2018, \u201cAnti-m\u00fcllerian hormone in the pathophysiology and diagnosis of polycystic ovarian syndrome,\u201d journals.lww.com, 2018, https:\/\/doi.org\/10.1097\/MED.0000000000000445","DOI":"10.1097\/MED.0000000000000445"},{"key":"2625_CR107","doi-asserted-by":"publisher","unstructured":"S. Franks, C. Gilling-Smith, N. Gharani, and M. McCarthy, \u201cPathogenesis of polycystic ovary syndrome: evidence for a genetically determined disorder of ovarian androgen production,\u201d, 3, 2:77\u201379, 2009, https:\/\/doi.org\/10.1080\/1464727002000198731","DOI":"10.1080\/1464727002000198731"},{"issue":"3","key":"2625_CR108","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1093\/HMG\/6.3.397","volume":"6","author":"N Gharani","year":"1997","unstructured":"Gharani N, et al. Association of the steroid synthesis gene Cyp11a with polycystic ovary syndrome and hyperandrogenism. Hum Mol Genet. 1997;6(3):397\u2013402. https:\/\/doi.org\/10.1093\/HMG\/6.3.397.","journal-title":"Hum Mol Genet"},{"issue":"7","key":"2625_CR109","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1007\/S10815-014-0236-X\/TABLES\/3","volume":"31","author":"KR Reddy","year":"2014","unstructured":"Reddy KR, et al. CYP11A1 microsatellite (tttta)n polymorphism in PCOS women from South India. J Assist Reprod Genet. 2014;31(7):857\u201363. https:\/\/doi.org\/10.1007\/S10815-014-0236-X\/TABLES\/3.","journal-title":"J Assist Reprod Genet"},{"issue":"8","key":"2625_CR110","doi-asserted-by":"publisher","first-page":"8379","DOI":"10.1007\/S11033-012-1688-7\/TABLES\/7","volume":"39","author":"CW Zhang","year":"2012","unstructured":"Zhang CW, et al. Association between polymorphisms of the CYP11A1 gene and polycystic ovary syndrome in Chinese women. Mol Biol Rep. 2012;39(8):8379\u201385. https:\/\/doi.org\/10.1007\/S11033-012-1688-7\/TABLES\/7.","journal-title":"Mol Biol Rep"},{"issue":"5","key":"2625_CR111","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1016\/S0015-0282(16)53510-9","volume":"53","author":"RL Rosenfield","year":"1990","unstructured":"Rosenfield RL, Barnes RB, Cara JF, Lucky AW. Dysregulation of cytochrome P450c17\u03b1 as the cause of polycystic ovarian syndrome. Fertil Steril. 1990;53(5):785\u201391. https:\/\/doi.org\/10.1016\/S0015-0282(16)53510-9.","journal-title":"Fertil Steril"},{"issue":"6","key":"2625_CR112","doi-asserted-by":"publisher","first-page":"1686","DOI":"10.1210\/JCEM.79.6.7989476","volume":"79","author":"RL Rosenfield","year":"1994","unstructured":"Rosenfield RL, Barnes RB, Ehrmann DA. Studies of the nature of 17-hydroxyprogesterone hyperresonsiveness to gonadotropin-releasing hormone agonist challenge in functional ovarian hyperandrogenism. J Clin Endocrinol Metab. 1994;79(6):1686\u201392. https:\/\/doi.org\/10.1210\/JCEM.79.6.7989476.","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"2625_CR113","doi-asserted-by":"publisher","first-page":"1873","DOI":"10.1093\/HMG\/3.10.1873","volume":"3","author":"AH Carey","year":"1994","unstructured":"Carey AH, et al. Polycystic ovaries and premature male pattern baldness are associated with one allele of the steroid metabolism gene CYP17. Hum Mol Genet. 1994;3(10):1873\u20136. https:\/\/doi.org\/10.1093\/HMG\/3.10.1873.","journal-title":"Hum Mol Genet"},{"issue":"23","key":"2625_CR114","doi-asserted-by":"publisher","first-page":"10619","DOI":"10.1073\/PNAS.92.23.10619","volume":"92","author":"LH Zhang","year":"1995","unstructured":"Zhang LH, Rodriguez H, Ohno S, Miller WL. Serine phosphorylation of human P450c17 increases 17,20-lyase activity: implications for adrenarche and the polycystic ovary syndrome. Proc Natl Acad Sci. 1995;92(23):10619\u201323. https:\/\/doi.org\/10.1073\/PNAS.92.23.10619.","journal-title":"Proc Natl Acad Sci"},{"key":"2625_CR115","doi-asserted-by":"publisher","unstructured":"D. W. Nebert et al., \u201cThe P450 gene superfamily: recommended nomenclature,\u201d http:\/\/www.liebertpub.com\/dna, 6, 1:1\u201311, 2009, https:\/\/doi.org\/10.1089\/DNA.1987.6.1.","DOI":"10.1089\/DNA.1987.6.1"},{"key":"2625_CR116","doi-asserted-by":"publisher","unstructured":"S. Chen et al., \u201cHuman Aromatase: cDNA cloning, southern blot analysis, and assignment of the gene to chromosome 15,\u201d http:\/\/www.liebertpub.com\/dna, 7, 1:27\u201338, 2009, https:\/\/doi.org\/10.1089\/DNA.1988.7.27.","DOI":"10.1089\/DNA.1988.7.27"},{"issue":"7","key":"2625_CR117","doi-asserted-by":"publisher","first-page":"4781","DOI":"10.1016\/S0021-9258(18)42900-6","volume":"267","author":"N Harada","year":"1992","unstructured":"Harada N, et al. Biochemical and molecular genetic analyses on placental aromatase (P-450AROM) deficiency. J Biol Chem. 1992;267(7):4781\u20135. https:\/\/doi.org\/10.1016\/S0021-9258(18)42900-6.","journal-title":"J Biol Chem"},{"issue":"24","key":"2625_CR118","doi-asserted-by":"publisher","first-page":"11673","DOI":"10.1073\/PNAS.90.24.11673","volume":"90","author":"Y Ito","year":"1993","unstructured":"Ito Y, Fisher CR, Conte FA, Grumbach MM, Simpson ER. Molecular basis of aromatase deficiency in an adult female with sexual infantilism and polycystic ovaries. Proc Natl Acad Sci. 1993;90(24):11673\u20137. https:\/\/doi.org\/10.1073\/PNAS.90.24.11673.","journal-title":"Proc Natl Acad Sci"},{"issue":"1","key":"2625_CR119","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/MOLEHR\/4.1.1","volume":"4","author":"AJ Jakimiuk","year":"1998","unstructured":"Jakimiuk AJ, Weitsman SR, Brzechffa PR, Magoffin DA. Aromatase mRNA expression in individual follicles from polycystic ovaries. Mol Hum Reprod. 1998;4(1):1\u20138. https:\/\/doi.org\/10.1093\/MOLEHR\/4.1.1.","journal-title":"Mol Hum Reprod"},{"key":"2625_CR120","doi-asserted-by":"publisher","unstructured":"J. L. Jin et al., \u201cAssociation between CYP19 gene SNP rs2414096 polymorphism and polycystic ovary syndrome in Chinese women.,\u201d BMC Med Genet, 10, 1:139, 2009, https:\/\/doi.org\/10.1186\/1471-2350-10-139\/TABLES\/3.","DOI":"10.1186\/1471-2350-10-139\/TABLES\/3"},{"issue":"3","key":"2625_CR121","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1016\/S0015-0282(16)56940-4","volume":"62","author":"H Escobar-Morreale","year":"1994","unstructured":"Escobar-Morreale H, Pazos F, Potau N, Garcia-Robles R, Sancho JM, Varela C. Ovarian suppression with triptorelin and adrenal stimulation with adrenocorticotropin in functional hyperadrogenism: role of adrenal and ovarian cytochrome P450c17\u03b1. Fertil Steril. 1994;62(3):521\u201330. https:\/\/doi.org\/10.1016\/S0015-0282(16)56940-4.","journal-title":"Fertil Steril"},{"issue":"2","key":"2625_CR122","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1210\/JCEM.80.2.7852496","volume":"80","author":"R Azziz","year":"1995","unstructured":"Azziz R, Bradley EL, Potter HD, Boots LR. Adrenal androgen excess in women: lack of a role for 17-hydroxylase and 17,20-lyase dysregulation. J Clin Endocrinol Metab. 1995;80(2):400\u20135. https:\/\/doi.org\/10.1210\/JCEM.80.2.7852496.","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2625_CR123","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1016\/J.FERTNSTERT.2004.10.027","volume":"83","author":"SF Witchel","year":"2005","unstructured":"Witchel SF, Kahsar-Miller M, Aston CE, White C, Azziz R. Prevalence of CYP21 mutations and IRS1 variant among women with polycystic ovary syndrome and adrenal androgen excess. Fertil Steril. 2005;83(2):371\u20135. https:\/\/doi.org\/10.1016\/J.FERTNSTERT.2004.10.027.","journal-title":"Fertil Steril"},{"key":"2625_CR124","doi-asserted-by":"publisher","unstructured":"D. B. Lubahn, D. R. Joseph, P. M. Sullivan, H. F. Willard, F. S. French, and E. M. Wilson, \u201cCloning of human androgen receptor complementary dna and localization to the X chromosome,\u201d Science (1979), 240, 4850:327\u2013330, 1988, https:\/\/doi.org\/10.1126\/SCIENCE.3353727.","DOI":"10.1126\/SCIENCE.3353727"},{"issue":"9","key":"2625_CR125","doi-asserted-by":"publisher","first-page":"3484","DOI":"10.1210\/JCEM.85.9.6832","volume":"85","author":"A Mifsud","year":"2000","unstructured":"Mifsud A, Ramirez S, Yong EL. Androgen receptor gene cag trinucleotide repeats in anovulatory infertility and polycystic ovaries. J Clin Endocrinol Metab. 2000;85(9):3484\u20138. https:\/\/doi.org\/10.1210\/JCEM.85.9.6832.","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"2625_CR126","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1016\/0960-0760(90)90358-R","volume":"37","author":"SEJ Edmunds","year":"1990","unstructured":"Edmunds SEJ, Stubbs AP, Santos AA, Wilkinson ML. Estrogen and androgen regulation of sex hormone binding globulin secretion by a human liver cell line. J Steroid Biochem Mol Biol. 1990;37(5):733\u20139. https:\/\/doi.org\/10.1016\/0960-0760(90)90358-R.","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"1","key":"2625_CR127","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1210\/JCEM-72-1-83","volume":"72","author":"JE Nestler","year":"1991","unstructured":"Nestler JE, et al. A direct effect of hyperinsulinemia on serum sex hormone-binding globulin levels in obese women with the polycystic ovary syndrome. J Clin Endocrinol Metab. 1991;72(1):83\u20139. https:\/\/doi.org\/10.1210\/JCEM-72-1-83.","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"2625_CR128","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1177\/000456329002700603","volume":"27","author":"C Selby","year":"1990","unstructured":"Selby C. Sex hormone binding globulin: origin, function and clinical significance. Ann Clin Biochem. 1990;27(6):532\u201341. https:\/\/doi.org\/10.1177\/000456329002700603.","journal-title":"Ann Clin Biochem"},{"issue":"1\u20132","key":"2625_CR129","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1159\/000132958","volume":"54","author":"D B\u00e9rub\u00e9","year":"1990","unstructured":"B\u00e9rub\u00e9 D, S\u00e9ralini GE, Gagn\u00e9 R, Hammond GL. Localization of the human sex hormone-binding globulin gene (SHBG) to the short arm of chromosome 17 (17p12\u2192p13). Cytogenet Genome Res. 1990;54(1\u20132):65\u20137. https:\/\/doi.org\/10.1159\/000132958.","journal-title":"Cytogenet Genome Res"},{"issue":"12","key":"2625_CR130","doi-asserted-by":"publisher","first-page":"5976","DOI":"10.1210\/JC.2003-030197","volume":"88","author":"N Xita","year":"2003","unstructured":"Xita N, Tsatsoulis A, Chatzikyriakidou A, Georgiou I. Association of the (TAAAA)n repeat polymorphism in the sex hormone-binding globulin (SHBG) gene with polycystic ovary syndrome and relation to SHBG serum levels. J Clin Endocrinol Metab. 2003;88(12):5976\u201380. https:\/\/doi.org\/10.1210\/JC.2003-030197.","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"2625_CR131","doi-asserted-by":"publisher","first-page":"E719","DOI":"10.1210\/JC.2010-1842","volume":"96","author":"EP Wickham","year":"2011","unstructured":"Wickham EP, Ewens KG, Legro RS, Dunaif A, Nestler JE, Strauss JF. Polymorphisms in the SHBG gene influence serum SHBG levels in women with polycystic ovary syndrome. J Clin Endocrinol Metab. 2011;96(4):E719\u201327. https:\/\/doi.org\/10.1210\/JC.2010-1842.","journal-title":"J Clin Endocrinol Metab"},{"key":"2625_CR132","unstructured":"C. Chen, J. Smothers, A. Lange, J. E. Nestler, J. F. Strauss, and E. P. Wickham, \u201cSex hormone-binding globulin genetic variation: associations with type 2 diabetes mellitus and polycystic ovary syndrome,\u201d Minerva Endocrinol, vol. 35, no. 4, p. 271, Dec. 2010, Accessed: Jan. 24, 2022. [Online]. Available: \/pmc\/articles\/PMC3683392\/"},{"issue":"1","key":"2625_CR133","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1210\/JCEM.78.1.7904610","volume":"78","author":"K Furui","year":"1994","unstructured":"Furui K, et al. Identification of two point mutations in the gene coding luteinizing hormone (LH) beta-subunit, associated with immunologically anomalous LH variants. J Clin Endocrinol Metab. 1994;78(1):107\u201313. https:\/\/doi.org\/10.1210\/JCEM.78.1.7904610.","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2625_CR134","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1006\/BBRC.1994.1488","volume":"200","author":"K Okuda","year":"1994","unstructured":"Okuda K, Yamada T, Imoto H, Komatsubara H, Sugimoto O. Antigenic Alteration of an Anomalous Human Luteinizing Hormone Caused by Two Chorionic Gonadotropin-Type Amino-Acid Substitutions. Biochem Biophys Res Commun. 1994;200(1):584\u201390. https:\/\/doi.org\/10.1006\/BBRC.1994.1488.","journal-title":"Biochem Biophys Res Commun"},{"issue":"4","key":"2625_CR135","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1210\/JCEM.80.4.7714098","volume":"80","author":"AM Haavisto","year":"1995","unstructured":"Haavisto AM, Pettersson K, Bergendahl M, Virkam\u00e4ki A, Huhtaniemi I. Occurrence and biological properties of a common genetic variant of luteinizing hormone. J Clin Endocrinol Metab. 1995;80(4):1257\u201363. https:\/\/doi.org\/10.1210\/JCEM.80.4.7714098.","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2625_CR136","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1007\/BF00229477","volume":"165","author":"AC Roy","year":"1996","unstructured":"Roy AC, Liao WX, Chen Y, Arulkumaran S, Ratnam SS. Identification of seven novel mutations in LH \u03b2-subunit gene by SSCP. Mol Cellular Biochem. 1996;165(2):151\u20133. https:\/\/doi.org\/10.1007\/BF00229477.","journal-title":"Mol Cellular Biochem."},{"issue":"5","key":"2625_CR137","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1038\/sj.ejhg.5200968","volume":"11","author":"K Takahashi","year":"2003","unstructured":"Takahashi K, et al. Influence of missense mutation and silent mutation of LH\u03b2-subunit gene in Japanese patients with ovulatory disorders. Eur J Human Genet. 2003;11(5):402\u20138. https:\/\/doi.org\/10.1038\/sj.ejhg.5200968.","journal-title":"Eur J Human Genet"},{"issue":"4","key":"2625_CR138","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1093\/HUMUPD\/7.4.405","volume":"7","author":"S Franks","year":"2001","unstructured":"Franks S, Gharani N, McCarthy M. Candidate genes in polycystic ovary syndrome. Hum Reprod Update. 2001;7(4):405\u201310. https:\/\/doi.org\/10.1093\/HUMUPD\/7.4.405.","journal-title":"Hum Reprod Update"},{"key":"2625_CR139","doi-asserted-by":"publisher","unstructured":"A. Al-Hayawi, \u201cThe FSHR polymorphisms association with polycystic ovary syndrome in women of Erbil, Kurdistan in North of Iraq\u201d, https:\/\/doi.org\/10.30526\/2017.IHSCICONF.1799.","DOI":"10.30526\/2017.IHSCICONF.1799"},{"issue":"8","key":"2625_CR140","doi-asserted-by":"publisher","first-page":"2862","DOI":"10.1210\/JC.2017-00612","volume":"102","author":"LK Gorsic","year":"2017","unstructured":"Gorsic LK, et al. Pathogenic Anti-M\u00fcllerian hormone variants in polycystic ovary syndrome. J Clin Endocrinol Metab. 2017;102(8):2862\u201372. https:\/\/doi.org\/10.1210\/JC.2017-00612.","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"2625_CR141","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1530\/REP.0.1210503","volume":"121","author":"PG Knight","year":"2001","unstructured":"Knight PG, Glister C. Potential local regulatory functions of inhibins, activins and follistatin in the ovary. Reprod. 2001;121(4):503\u201312. https:\/\/doi.org\/10.1530\/REP.0.1210503.","journal-title":"Reprod"},{"issue":"1","key":"2625_CR142","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1210\/MEND.12.1.0053","volume":"12","author":"Q Guo","year":"1998","unstructured":"Guo Q, Kumar TR, Woodruff T, Hadsell LA, Demayo FJ, Matzuk MM. Overexpression of mouse follistatin causes reproductive defects in transgenic mice. Mol Endocrinol. 1998;12(1):96\u2013106. https:\/\/doi.org\/10.1210\/MEND.12.1.0053.","journal-title":"Mol Endocrinol"},{"issue":"9","key":"2625_CR143","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.2337\/DIAB.38.9.1165","volume":"38","author":"A Dunaif","year":"1989","unstructured":"Dunaif A, Segal KR, Futterweit W, Dobrjansky A. Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome. Diabetes. 1989;38(9):1165\u201374. https:\/\/doi.org\/10.2337\/DIAB.38.9.1165.","journal-title":"Diabetes"},{"issue":"1","key":"2625_CR144","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1210\/EN.2003-0329","volume":"145","author":"I Munir","year":"2004","unstructured":"Munir I, et al. Insulin augmentation of 17\u03b1-hydroxylase activity is mediated by phosphatidyl inositol 3-kinase but not extracellular signal-regulated kinase-1\/2 in human ovarian theca cells. Endocrinol. 2004;145(1):175\u201383. https:\/\/doi.org\/10.1210\/EN.2003-0329.","journal-title":"Endocrinol"},{"key":"2625_CR145","doi-asserted-by":"publisher","unstructured":"N. Cataldo, L. Giudice, L. Poretsky, N. A. Cataldo, Z. Rosenwaks, and L. C. Giudice, \u201cThe insulin-related ovarian regulatory system in health and disease,\u201d 1999, https:\/\/doi.org\/10.1210\/edrv.20.4.0374.","DOI":"10.1210\/edrv.20.4.0374"},{"issue":"1\u20134","key":"2625_CR146","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1159\/000133007","volume":"55","author":"C Junien","year":"1990","unstructured":"Junien C, van Heyningen V. Report of the committee on the genetic constitution of chromosome 11. Cytogenet Genome Res. 1990;55(1\u20134):153\u201369. https:\/\/doi.org\/10.1159\/000133007.","journal-title":"Cytogenet Genome Res"},{"issue":"5844","key":"2625_CR147","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1038\/295031a0","volume":"295","author":"GI Bell","year":"1982","unstructured":"Bell GI, Selby MJ, Rutter WJ. The highly polymorphic region near the human insulin gene is composed of simple tandemly repeating sequences. Nature. 1982;295(5844):31\u20135. https:\/\/doi.org\/10.1038\/295031a0.","journal-title":"Nature"},{"issue":"9057","key":"2625_CR148","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1016\/S0140-6736(96)08368-7","volume":"349","author":"DM Waterworth","year":"1997","unstructured":"Waterworth DM, et al. Linkage and association of insulin gene VNTR regulatory polymorphism with polycystic ovary syndrome. Lancet. 1997;349(9057):986\u201390. https:\/\/doi.org\/10.1016\/S0140-6736(96)08368-7.","journal-title":"Lancet"},{"issue":"3","key":"2625_CR149","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1210\/EDRV-8-3-235","volume":"8","author":"ID Goldfine","year":"1987","unstructured":"Goldfine ID. The insulin receptor: molecular biology and transmembrane signaling. Endocr Rev. 1987;8(3):235\u201355. https:\/\/doi.org\/10.1210\/EDRV-8-3-235.","journal-title":"Endocr Rev"},{"issue":"12","key":"2625_CR150","doi-asserted-by":"publisher","first-page":"1568","DOI":"10.1016\/0026-0495(94)90018-3","volume":"43","author":"LR Sorbara","year":"1994","unstructured":"Sorbara LR, et al. Absence of insulin receptor gene mutations in three insulin-resistant women with the polycystic ovary syndrome. Metabolism. 1994;43(12):1568\u201374. https:\/\/doi.org\/10.1016\/0026-0495(94)90018-3.","journal-title":"Metabolism"},{"issue":"5","key":"2625_CR151","doi-asserted-by":"publisher","first-page":"1979","DOI":"10.1210\/JCEM.81.5.8626868","volume":"81","author":"JA Talbot","year":"1996","unstructured":"Talbot JA, Bicknell EJ, Rajkhowa M, Krook A, O\u2019Rahilly S, Clayton RN. Molecular scanning of the insulin receptor gene in women with polycystic ovarian syndrome. J Clin Endocrinol Metab. 1996;81(5):1979\u201383. https:\/\/doi.org\/10.1210\/JCEM.81.5.8626868.","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2625_CR152","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1210\/JCEM.86.1.7274","volume":"86","author":"S Tucci","year":"2001","unstructured":"Tucci S, et al. Evidence for association of polycystic ovary syndrome in caucasian women with a marker at the insulin receptor gene locus. J Clin Endocrinol Metab. 2001;86(1):446\u20139. https:\/\/doi.org\/10.1210\/JCEM.86.1.7274.","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"2625_CR153","doi-asserted-by":"publisher","first-page":"6623","DOI":"10.1210\/JC.2005-0622","volume":"90","author":"M Urbanek","year":"2005","unstructured":"Urbanek M, et al. Candidate gene region for polycystic ovary syndrome on chromosome 19p13.2. J Clin Endocrinol Metab. 2005;90(12):6623\u20139. https:\/\/doi.org\/10.1210\/JC.2005-0622.","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"2625_CR154","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1016\/S0015-0282(02)04241-3","volume":"78","author":"S Siegel","year":"2002","unstructured":"Siegel S, et al. A C\/T single nucleotide polymorphism at the tyrosine kinase domain of the insulin receptor gene is associated with polycystic ovary syndrome. Fertil Steril. 2002;78(6):1240\u20133. https:\/\/doi.org\/10.1016\/S0015-0282(02)04241-3.","journal-title":"Fertil Steril"},{"issue":"3","key":"2625_CR155","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1152\/AJPENDO.00514.2001\/ASSET\/IMAGES\/LARGE\/H10920962005.JPEG","volume":"283","author":"MF White","year":"2002","unstructured":"White MF. IRS proteins and the common path to diabetes. Am J Physiol - Endocrinol Metab. 2002;283(3):46\u201353. https:\/\/doi.org\/10.1152\/AJPENDO.00514.2001\/ASSET\/IMAGES\/LARGE\/H10920962005.JPEG.","journal-title":"Am J Physiol - Endocrinol Metab"},{"key":"2625_CR156","unstructured":"\u201cG972R polymorphism of IRS-1 in women with polycystic ovary syndrome - ProQuest.\u201d https:\/\/www.proquest.com\/openview\/1eb37ce5cc2b3d46b73650d49adb6791\/1?pq-origsite=gscholar&cbl=48469 (accessed Jan. 30, 2022)."},{"issue":"2","key":"2625_CR157","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/J.FERTNSTERT.2005.01.133","volume":"84","author":"S Dilek","year":"2005","unstructured":"Dilek S, Ertunc D, Tok EC, Erdal EM, Aktas A. Association of Gly972Arg variant of insulin receptor substrate-1 with metabolic features in women with polycystic ovary syndrome. Fertil Steril. 2005;84(2):407\u201312. https:\/\/doi.org\/10.1016\/J.FERTNSTERT.2005.01.133.","journal-title":"Fertil Steril"},{"issue":"12","key":"2625_CR158","doi-asserted-by":"publisher","first-page":"2099","DOI":"10.1096\/FJ.01-0009REV","volume":"15","author":"G Sesti","year":"2001","unstructured":"Sesti G, Federici M, Hribal ML, Lauro D, Sbraccia P, Lauro R. Defects of the insulin receptor substrate (IRS) system in human metabolic disorders. FASEB J. 2001;15(12):2099\u2013111. https:\/\/doi.org\/10.1096\/FJ.01-0009REV.","journal-title":"FASEB J"},{"key":"2625_CR159","doi-asserted-by":"crossref","unstructured":"P. Gual, Y. le Marchand-Brustel, J. T.- Biochimie, and undefined 2005, \u201cPositive and negative regulation of insulin signaling through IRS-1 phosphorylation,\u201d Elsevier, Accessed: Aug. 21, 2022. [Online]. Available: https:\/\/www.sciencedirect.com\/science\/article\/pii\/S0300908404001981","DOI":"10.1016\/j.biochi.2004.10.019"},{"issue":"47","key":"2625_CR160","doi-asserted-by":"publisher","first-page":"29911","DOI":"10.1074\/jbc.272.47.29911","volume":"272","author":"K Paz","year":"1997","unstructured":"Paz K, et al. A molecular basis for insulin resistance. J Biol Chem. 1997;272(47):29911\u20138. https:\/\/doi.org\/10.1074\/jbc.272.47.29911.","journal-title":"J Biol Chem"},{"key":"2625_CR161","unstructured":"H. Kanety, R. Feinstein, M. Papa, \u2026 R. H.-J. of B., and undefined 1995, \u201cTumor necrosis factor \u03b1-induced phosphorylation of insulin receptor substrate-1 (IRS-1): POSSIBLE MECHANISM FOR SUPPRESSION OF INSULIN,\u201d ASBMB, Accessed: Aug. 21, 2022. [Online]. Available: https:\/\/www.jbc.org\/article\/S0021-9258(18)89979-3\/abstract"},{"issue":"52","key":"2625_CR162","doi-asserted-by":"publisher","first-page":"50230","DOI":"10.1074\/jbc.M200958200","volume":"277","author":"C Yu","year":"2002","unstructured":"Yu C, et al. Mechanism by which fatty acids inhibit insulin activation of insulin receptor substrate-1 (IRS-1)-associated phosphatidylinositol 3-kinase activity in muscle. J Biol Chem. 2002;277(52):50230\u20136. https:\/\/doi.org\/10.1074\/jbc.M200958200.","journal-title":"J Biol Chem"},{"key":"2625_CR163","doi-asserted-by":"crossref","unstructured":"P. Gual, T. Gonzalez, T. Gr\u00e9meaux, \u2026 R. B.-J. of B., and undefined 2003, \u201cHyperosmotic stress inhibits insulin receptor substrate-1 function by distinct mechanisms in 3T3-L1 adipocytes,\u201d ASBMB, Accessed: Aug. 21, 2022. [Online]. Available: https:\/\/www.jbc.org\/article\/S0021-9258(20)84607-9\/abstract","DOI":"10.1074\/jbc.M212273200"},{"issue":"5","key":"2625_CR164","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1007\/S00125-003-1097-5\/FIGURES\/7","volume":"46","author":"R Potashnik","year":"2003","unstructured":"Potashnik R, Bloch-Damti A, Bashan N, Rudich A. IRS1 degradation and increased serine phosphorylation cannot predict the degree of metabolic insulin resistance induced by oxidative stress. Diabetologia. 2003;46(5):639\u201348. https:\/\/doi.org\/10.1007\/S00125-003-1097-5\/FIGURES\/7.","journal-title":"Diabetologia"},{"key":"2625_CR165","unstructured":"A. Dunaif, J. Xia, C. Book, \u2026 E. S.-T. J. of clinical, and undefined 1995, \u201cExcessive insulin receptor serine phosphorylation in cultured fibroblasts and in skeletal muscle. A potential mechanism for insulin resistance in the polycystic ovary,\u201d Am Soc Clin Investig, Accessed: Aug. 21, 2022. [Online]. Available: https:\/\/www.jci.org\/articles\/view\/118126"},{"issue":"5","key":"2625_CR166","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1152\/AJPENDO.00361.2004","volume":"288","author":"A Corbould","year":"2005","unstructured":"Corbould A, et al. Insulin resistance in the skeletal muscle of women with PCOS involves intrinsic and acquired defects in insulin signaling. Am J Physiol - Endocrinol Metab. 2005;288(5):51\u20135. https:\/\/doi.org\/10.1152\/AJPENDO.00361.2004.","journal-title":"Am J Physiol - Endocrinol Metab"},{"key":"2625_CR167","doi-asserted-by":"crossref","unstructured":"A. Corbould, H. Zhao, S. Mirzoeva, F. Aird, and A. Dunaif, \u201cEnhanced mitogenic signaling in skeletal muscle of women with polycystic ovary syndrome,\u201d Diabetes, vol. 55, no. 3, pp. 751\u2013760, Mar. 2006, Accessed: Aug. 21, 2022. [Online]. Available: https:\/\/go.gale.com\/ps\/i.do?p=AONE&sw=w&issn=00121797&v=2.1&it=r&id=GALE%7CA143248675&sid=googleScholar&linkaccess=fulltext","DOI":"10.2337\/diabetes.55.03.06.db05-0453"},{"key":"2625_CR168","unstructured":"E. Velazquez, S. Mendoza, T. Hamer, F. S.- Metabolism, and undefined 1994, \u201cMetformin therapy in polycystic ovary syndrome reduces hyperinsulinemia, insulin resistance, hyperandrogenemia, and systolic blood pressure, while facilitating,\u201d Elsevier, Accessed: Aug. 21, 2022. [Online]. Available: https:\/\/www.sciencedirect.com\/science\/article\/pii\/0026049594902097"},{"key":"2625_CR169","unstructured":"R. Dumitrescu, \u201cMetformin-clinical pharmacology in PCOs,\u201d Journal of Medicine and Life, vol. 8, pp. 187\u2013192."},{"key":"2625_CR170","doi-asserted-by":"crossref","unstructured":"H. Escobar-Morreale, \u2026 E. C.-H. reproduction, and undefined 2012, \u201cEpidemiology, diagnosis and management of hirsutism: a consensus statement by the Androgen Excess and Polycystic Ovary Syndrome Society,\u201d academic.oup.com, Accessed: Aug. 21, 2022. [Online]. Available: https:\/\/academic.oup.com\/humupd\/article-abstract\/18\/2\/146\/618266","DOI":"10.1093\/humupd\/dmr042"},{"issue":"5","key":"2625_CR171","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1038\/NCPENDMET0787","volume":"4","author":"A Dunaif","year":"2008","unstructured":"Dunaif A. Drug Insight: Insulin-sensitizing drugs in the treatment of polycystic ovary syndrome - a reappraisal. Nat Clin Pract Endocrinol Metab. 2008;4(5):272\u201383. https:\/\/doi.org\/10.1038\/NCPENDMET0787.","journal-title":"Nat Clin Pract Endocrinol Metab"},{"key":"2625_CR172","unstructured":"K. Blomquist, V. Milsom, R. Barnes, \u2026 A. B.-C., and undefined 2012, \u201cMetabolic syndrome in obese men and women with binge eating disorder: developmental trajectories of eating and weight-related behaviors,\u201d Elsevier, Accessed: Aug. 21, 2022. [Online]. Available: https:\/\/www.sciencedirect.com\/science\/article\/pii\/S0010440X12000272"},{"key":"2625_CR173","doi-asserted-by":"publisher","unstructured":"T Tang RJ Norman AH Balen JM Lord 2003 Insulin-sensitising drugs (metformin, troglitazone, rosiglitazone, pioglitazone, D-chiro-inositol) for polycystic ovary syndrome Cochrane Database Syst Revhttps:\/\/doi.org\/10.1002\/14651858.CD003053","DOI":"10.1002\/14651858.CD003053"},{"key":"2625_CR174","unstructured":"G. Attia, W. Rainey, B. C.-F. and sterility, and undefined 2001, \u201cMetformin directly inhibits androgen production in human thecal cells,\u201d Elsevier, Accessed: Aug. 21, 2022. [Online]. Available: https:\/\/www.sciencedirect.com\/science\/article\/pii\/S0015028201019756?casa_token=kndwMryayKIAAAAA:lZrv1YXr-yJzXhJGMshXQx12j6blX0mdSjJF0myv0603DHP9XWYFSxcvTR6wUXeQO7XOJMdcya8"},{"issue":"9","key":"2625_CR175","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1056\/NEJM199602293340906","volume":"334","author":"CJ Bailey","year":"1996","unstructured":"Bailey CJ, Turner RC. Metformin. N Engl J Med. 1996;334(9):574\u20139. https:\/\/doi.org\/10.1056\/NEJM199602293340906.","journal-title":"N Engl J Med"},{"key":"2625_CR176","unstructured":"S. Thatcher, E. J.-F. and sterility, and undefined 2006, \u201cPregnancy outcome in infertile patients with polycystic ovary syndrome who were treated with metformin,\u201d Elsevier, Accessed: Aug. 21, 2022. [Online]. Available: https:\/\/www.sciencedirect.com\/science\/article\/pii\/S0015028205042123?casa_token=OpclRqBuXV8AAAAA:LPjTc3bOEsCb5N0B0mrzb47b8dIUCV4uwhK3RpnFozx9JWfhzRv8iBCTXr6VMFbkWxIIPpGE9qM"},{"issue":"11","key":"2625_CR177","doi-asserted-by":"publisher","first-page":"2858","DOI":"10.1093\/HUMREP\/17.11.2858","volume":"17","author":"CJ Glueck","year":"2002","unstructured":"Glueck CJ, Wang P, Goldenberg N, Sieve-Smith L. Pregnancy outcomes among women with polycystic ovary syndrome treated with metformin. Hum Reprod. 2002;17(11):2858\u201364. https:\/\/doi.org\/10.1093\/HUMREP\/17.11.2858.","journal-title":"Hum Reprod"},{"key":"2625_CR178","unstructured":"R. Norman, J. Wang, W. H.-C. O. in Obstetrics, and undefined 2004, \u201cShould we continue or stop insulin sensitizing drugs during pregnancy?,\u201d journals.lww.com, Accessed: Aug. 21, 2022. [Online]. Available: https:\/\/journals.lww.com\/co-obgyn\/fulltext\/2004\/06000\/should_we_continue_or_stop_insulin_sensitizing.7.aspx?casa_token=fkq-L3704Q0AAAAA:UXhl-h-gdaFui3IMGmuE0kZhlxWUVrnPCKD3-SxagZCdvFMLLPTSJJxh787DInABN-KLWi08qmiX_YaDqQHa7vHywaiQIQ"},{"issue":"9","key":"2625_CR179","doi-asserted-by":"publisher","first-page":"2013","DOI":"10.2337\/DIABETES.50.9.2013","volume":"50","author":"SK Sreenan","year":"2001","unstructured":"Sreenan SK, et al. Calpains play a role in insulin secretion and action. Diabetes. 2001;50(9):2013\u201320. https:\/\/doi.org\/10.2337\/DIABETES.50.9.2013.","journal-title":"Diabetes"},{"key":"2625_CR180","doi-asserted-by":"publisher","unstructured":"Y. Horikawa et al., \u201cGenetic variation in the gene encoding calpain-10 is associated with type 2 diabetes mellitus,\u201d Nature Genetics 2000 26:2, vol. 26, no. 2, pp. 163\u2013175, Oct. 2000, doi: https:\/\/doi.org\/10.1038\/79876.","DOI":"10.1038\/79876"},{"issue":"8","key":"2625_CR181","doi-asserted-by":"publisher","first-page":"3971","DOI":"10.1210\/JCEM.87.8.8793","volume":"87","author":"A Gonzalez","year":"2002","unstructured":"Gonzalez A, et al. CAPN10 alleles are associated with polycystic ovary syndrome. J Clin Endocrinol Metab. 2002;87(8):3971\u20136. https:\/\/doi.org\/10.1210\/JCEM.87.8.8793.","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"2625_CR182","doi-asserted-by":"publisher","first-page":"5529","DOI":"10.1210\/JC.2003-030322","volume":"88","author":"A Gonzalez","year":"2003","unstructured":"Gonzalez A, et al. Specific CAPN10 gene haplotypes influence the clinical profile of polycystic ovary patients. J Clin Endocrinol Metab. 2003;88(11):5529\u201336. https:\/\/doi.org\/10.1210\/JC.2003-030322.","journal-title":"J Clin Endocrinol Metab"},{"key":"2625_CR183","doi-asserted-by":"publisher","unstructured":"H. F. Escobar-Morreale, B. Peral, G. Villuendas, R. M. Calvo, J. Sancho, and J. L. San Mill\u00e1n, \u201cCommon single nucleotide polymorphisms in intron 3 of the calpain-10 gene influence hirsutism,\u201d Fertility and Sterility, vol. 77, no. 3, pp. 581\u2013587, Mar. 2002, doi: https:\/\/doi.org\/10.1016\/S0015-0282(01)03206-X.","DOI":"10.1016\/S0015-0282(01)03206-X"},{"issue":"1","key":"2625_CR184","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1038\/NG.287","volume":"41","author":"CJ Willer","year":"2009","unstructured":"Willer CJ, et al. Six new loci associated with body mass index highlight a neuronal influence on body weight regulation. Nat Genet. 2009;41(1):25. https:\/\/doi.org\/10.1038\/NG.287.","journal-title":"Nat Genet"},{"issue":"1","key":"2625_CR185","doi-asserted-by":"publisher","first-page":"e86972","DOI":"10.1371\/JOURNAL.PONE.0086972","volume":"9","author":"X Cai","year":"2014","unstructured":"Cai X, Liu C, Mou S. Association between fat mass- and obesity- associated (FTO) gene polymorphism and polycystic ovary syndrome: a meta-analysis. PLoS ONE. 2014;9(1):e86972. https:\/\/doi.org\/10.1371\/JOURNAL.PONE.0086972.","journal-title":"PLoS ONE"},{"issue":"6","key":"2625_CR186","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/J.TIPS.2004.03.012","volume":"25","author":"SM Rangwala","year":"2004","unstructured":"Rangwala SM, Lazar MA. Peroxisome proliferator-activated receptor \u03b3 in diabetes and metabolism. Trends Pharmacol Sci. 2004;25(6):331\u20136. https:\/\/doi.org\/10.1016\/J.TIPS.2004.03.012.","journal-title":"Trends Pharmacol Sci"},{"issue":"10","key":"2625_CR187","doi-asserted-by":"publisher","first-page":"2416","DOI":"10.1172\/JCI119424","volume":"99","author":"AJ Vidal-Puig","year":"1997","unstructured":"Vidal-Puig AJ, et al. Peroxisome proliferator-activated receptor gene expression in human tissues. Effects of obesity, weight loss, and regulation by insulin and glucocorticoids. J Clin Investig. 1997;99(10):2416\u201322. https:\/\/doi.org\/10.1172\/JCI119424.","journal-title":"J Clin Investig"},{"issue":"9","key":"2625_CR188","doi-asserted-by":"publisher","first-page":"3299","DOI":"10.1210\/JCEM.81.9.8784087","volume":"81","author":"A Dunaif","year":"1996","unstructured":"Dunaif A, Scott D, Finegood D, Quintana B, Whitcomb R. The insulin-sensitizing agent troglitazone improves metabolic and reproductive abnormalities in the polycystic ovary syndrome. J Clin Endocrinol Metab. 1996;81(9):3299\u2013306. https:\/\/doi.org\/10.1210\/JCEM.81.9.8784087.","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"2625_CR189","doi-asserted-by":"publisher","first-page":"1626","DOI":"10.1210\/JCEM.86.4.7375","volume":"86","author":"R Azziz","year":"2001","unstructured":"Azziz R, et al. Troglitazone improves ovulation and hirsutism in the polycystic ovary syndrome: a multicenter, double blind, placebo-controlled trial. J Clin Endocrinol Metab. 2001;86(4):1626\u201332. https:\/\/doi.org\/10.1210\/JCEM.86.4.7375.","journal-title":"J Clin Endocrinol Metab"},{"issue":"1\u20132","key":"2625_CR190","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/J.YMGME.2004.08.014","volume":"83","author":"A Meirhaeghe","year":"2004","unstructured":"Meirhaeghe A, Amouyel P. Impact of genetic variation of PPAR\u03b3 in humans. Mol Genet Metab. 2004;83(1\u20132):93\u2013102. https:\/\/doi.org\/10.1016\/J.YMGME.2004.08.014.","journal-title":"Mol Genet Metab"},{"issue":"15","key":"2625_CR191","doi-asserted-by":"publisher","first-page":"8573","DOI":"10.1073\/PNAS.96.15.8573","volume":"96","author":"M Urbanek","year":"1999","unstructured":"Urbanek M, et al. Thirty-seven candidate genes for polycystic ovary syndrome: strongest evidence for linkage is with follistatin. Proc Natl Acad Sci. 1999;96(15):8573\u20138. https:\/\/doi.org\/10.1073\/PNAS.96.15.8573.","journal-title":"Proc Natl Acad Sci"},{"issue":"5","key":"2625_CR192","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1111\/J.1365-2265.2005.02261.X","volume":"62","author":"S Hahn","year":"2005","unstructured":"Hahn S, et al. The peroxisome proliferator activated receptor gamma Pro12Ala polymorphism is associated with a lower hirsutism score and increased insulin sensitivity in women with polycystic ovary syndrome. Clin Endocrinol. 2005;62(5):573\u20139. https:\/\/doi.org\/10.1111\/J.1365-2265.2005.02261.X.","journal-title":"Clin Endocrinol"},{"issue":"8","key":"2625_CR193","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1007\/S00109-012-0881-4\/FIGURES\/5","volume":"90","author":"F Qu","year":"2012","unstructured":"Qu F, et al. A molecular mechanism underlying ovarian dysfunction of polycystic ovary syndrome: hyperandrogenism induces epigenetic alterations in the granulosa cells. J Mol Med. 2012;90(8):911\u201323. https:\/\/doi.org\/10.1007\/S00109-012-0881-4\/FIGURES\/5.","journal-title":"J Mol Med"},{"key":"2625_CR194","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1016\/j.fertnstert.2016.01.029","volume":"105","author":"B Meczekalski","year":"2016","unstructured":"Meczekalski B, Katulski K, Podfigurna-Stopa A, Czyzyk A, Genazzani AD. Spontaneous endogenous pulsatile release of kisspeptin is temporally coupled with luteinizing hormone in healthy women. Elsevier. 2016;105:1345-1350.e2. https:\/\/doi.org\/10.1016\/j.fertnstert.2016.01.029.","journal-title":"Elsevier"},{"issue":"1","key":"2625_CR195","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1007\/S12020-018-1609-1","volume":"61","author":"K Katulski","year":"2018","unstructured":"Katulski K, Podfigurna A, Czyzyk A, Meczekalski B, Genazzani AD. Kisspeptin and LH pulsatile temporal coupling in PCOS patients. Endocrine. 2018;61(1):149\u201357. https:\/\/doi.org\/10.1007\/S12020-018-1609-1.","journal-title":"Endocrine"},{"key":"2625_CR196","doi-asserted-by":"publisher","unstructured":"E. A. Coutinho and A. S. Kauffman, \u201cThe role of the brain in the pathogenesis and physiology of polycystic ovary syndrome (PCOS),\u201d Medical Sciences, 7, 8:84, 2019, https:\/\/doi.org\/10.3390\/MEDSCI7080084.","DOI":"10.3390\/MEDSCI7080084"},{"key":"2625_CR197","doi-asserted-by":"crossref","unstructured":"R. Goodman, M. Lehman, J. Smith, \u2026 L. C.-, and undefined 2007, \u201cKisspeptin neurons in the arcuate nucleus of the ewe express both dynorphin A and neurokinin B,\u201d academic.oup.com, Accessed: Aug. 21, 2022. [Online]. Available: https:\/\/academic.oup.com\/endo\/article-abstract\/148\/12\/5752\/2501543","DOI":"10.1210\/en.2007-0961"},{"key":"2625_CR198","doi-asserted-by":"publisher","unstructured":"A. M. Moore, L. M. Coolen, and M. N. Lehman, \u201cIn vivo imaging of the GnRH pulse generator reveals a temporal order of neuronal activation and synchronization during each pulse,\u201d Proc Natl Acad Sci U S A, 119, 6, 2022, https:\/\/doi.org\/10.1073\/PNAS.2117767119.","DOI":"10.1073\/PNAS.2117767119"},{"key":"2625_CR199","doi-asserted-by":"crossref","unstructured":"J. Kawwass, K. Sanders, \u2026 T. L.-H., and undefined 2017, \u201cIncreased cerebrospinal fluid levels of GABA, testosterone and estradiol in women with polycystic ovary syndrome,\u201d academic.oup.com, Accessed: Aug. 21, 2022. [Online]. Available: https:\/\/academic.oup.com\/humrep\/article-abstract\/32\/7\/1450\/3770406","DOI":"10.1093\/humrep\/dex086"},{"issue":"18","key":"2625_CR200","doi-asserted-by":"publisher","first-page":"7129","DOI":"10.1073\/PNAS.0308058101","volume":"101","author":"SD Sullivan","year":"2004","unstructured":"Sullivan SD, Moenter SM. Prenatal androgens alter GABAergic drive to gonadotropin-releasing hormone neurons: implications for a common fertility disorder. Proc Natl Acad Sci. 2004;101(18):7129\u201334. https:\/\/doi.org\/10.1073\/PNAS.0308058101.","journal-title":"Proc Natl Acad Sci"},{"key":"2625_CR201","doi-asserted-by":"crossref","unstructured":"A. Moore, M. Prescott, R. C.- Endocrinology, and undefined 2013, \u201cEstradiol negative and positive feedback in a prenatal androgen-induced mouse model of polycystic ovarian syndrome,\u201d academic.oup.com, Accessed: Aug. 21, 2022. [Online]. Available: https:\/\/academic.oup.com\/endo\/article-abstract\/154\/2\/796\/2423496","DOI":"10.1210\/en.2012-1954"},{"issue":"2","key":"2625_CR202","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1073\/PNAS.1415038112\/SUPPL_FILE\/PNAS.201415038SI.PDF","volume":"112","author":"AM Moore","year":"2015","unstructured":"Moore AM, Prescott M, Marshall CJ, Yip SH, Campbell RE, McEwen BS. Enhancement of a robust arcuate GABAergic input to gonadotropin-releasing hormone neurons in a model of polycystic ovarian syndrome. Proc Natl Acad Sci U S A. 2015;112(2):596\u2013601. https:\/\/doi.org\/10.1073\/PNAS.1415038112\/SUPPL_FILE\/PNAS.201415038SI.PDF.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2625_CR203","doi-asserted-by":"crossref","unstructured":"S. Chhabra, C. McCartney, \u2026 R. Y.-T. J. of, and undefined 2005, \u201cProgesterone inhibition of the hypothalamic gonadotropin-releasing hormone pulse generator: evidence for varied effects in hyperandrogenemic adolescent girls,\u201d academic.oup.com, Accessed: Aug. 21, 2022. [Online]. Available: https:\/\/academic.oup.com\/jcem\/article-abstract\/90\/5\/2810\/2836855","DOI":"10.1210\/jc.2004-2359"},{"key":"2625_CR204","doi-asserted-by":"publisher","DOI":"10.1111\/JNE.13093)","author":"CR McCartney","year":"2022","unstructured":"McCartney CR, Campbell RE, Marshall JC, Moenter SM. The role of gonadotropin-releasing hormone neurons in polycystic ovary syndrome. J Neuroendocrinol. 2022. https:\/\/doi.org\/10.1111\/JNE.13093).","journal-title":"J Neuroendocrinol"},{"key":"2625_CR205","doi-asserted-by":"crossref","unstructured":"C. Eagleson, M. Gingrich, \u2026 C. P.-T. J. of, and undefined 2000, \u201cPolycystic ovarian syndrome: evidence that flutamide restores sensitivity of the gonadotropin-releasing hormone pulse generator to inhibition by estradiol and,\u201d academic.oup.com, Accessed: Aug. 21, 2022. [Online]. Available: https:\/\/academic.oup.com\/jcem\/article-abstract\/85\/11\/4047\/2852619","DOI":"10.1210\/jc.85.11.4047"},{"issue":"1","key":"2625_CR206","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1210\/endocr\/bqz038","volume":"161","author":"EA Dulka","year":"2020","unstructured":"Dulka EA, Burger LL, Moenter SM. Ovarian androgens maintain high GnRH neuron firing rate in adult prenatally-androgenized female mice. Endocrinology. 2020;161(1):1\u201314. https:\/\/doi.org\/10.1210\/endocr\/bqz038.","journal-title":"Endocrinology"},{"key":"2625_CR207","doi-asserted-by":"crossref","unstructured":"M. Silva, M. Prescott, R. C.-J. insight, and undefined 2018, \u201cOntogeny and reversal of brain circuit abnormalities in a preclinical model of PCOS,\u201d ncbi.nlm.nih.gov, Accessed: Aug. 21, 2022. [Online]. Available: https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC5928858\/","DOI":"10.1172\/jci.insight.99405"},{"issue":"3","key":"2625_CR208","doi-asserted-by":"publisher","first-page":"221","DOI":"10.3892\/ETM.2022.11145)","volume":"23","author":"C Wang","year":"2022","unstructured":"Wang C, Wen Y-X, Mai Q-Y. Impact of metabolic disorders on endometrial receptivity in patients with polycystic ovary syndrome. Exp Ther Med. 2022;23(3):221. https:\/\/doi.org\/10.3892\/ETM.2022.11145).","journal-title":"Exp Ther Med"},{"key":"2625_CR209","doi-asserted-by":"publisher","unstructured":"G. F. Erickson and S. Shimasaki, \u201cThe spatiotemporal expression pattern of the bone morphogenetic protein family in rat ovary cell types during the estrous cycle,\u201d Reproductive Biology and Endocrinology, 1, 2003, https:\/\/doi.org\/10.1186\/1477-7827-1-9","DOI":"10.1186\/1477-7827-1-9"},{"key":"2625_CR210","doi-asserted-by":"crossref","unstructured":"S. Shimasaki, R. Moore, \u2026 F. O.-E., and undefined 2004, \u201cThe bone morphogenetic protein system in mammalian reproduction,\u201d academic.oup.com, Accessed: Aug. 22, 2022. [Online]. Available: https:\/\/academic.oup.com\/edrv\/article-abstract\/25\/1\/72\/2355266","DOI":"10.1210\/er.2003-0007"},{"issue":"1\u20132","key":"2625_CR211","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0303-7207(99)00185-9","volume":"159","author":"JA Elvin","year":"2000","unstructured":"Elvin JA, Yan C, Matzuk MM. Oocyte-expressed TGF-\u03b2 superfamily members in female fertility. Mol Cell Endocrinol. 2000;159(1\u20132):1\u20135. https:\/\/doi.org\/10.1016\/S0303-7207(99)00185-9.","journal-title":"Mol Cell Endocrinol"},{"issue":"11","key":"2625_CR212","doi-asserted-by":"publisher","first-page":"4951","DOI":"10.1210\/ENDO.136.11.7588229","volume":"136","author":"WM Baarends","year":"1995","unstructured":"Baarends WM, et al. Anti-m\u00fcllerian hormone and anti-m\u00fcllerian hormone type II receptor messenger ribonucleic acid expression in rat ovaries during postnatal development, the estrous cycle, and gonadotropin-induced follicle growth. Endocrinol. 1995;136(11):4951\u201362. https:\/\/doi.org\/10.1210\/ENDO.136.11.7588229.","journal-title":"Endocrinol"},{"issue":"2","key":"2625_CR213","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1002\/mrd.20359","volume":"73","author":"KR von Schalburg","year":"2006","unstructured":"von Schalburg KR, Mccarthy SP, Rise ML, Hutson JC, Davidson WS, Koop BF. Expression of morphogenic genes in mature ovarian and testicular tissues: potential stem-cell niche markers and patterning factors. Wiley Online Library. 2006;73(2):142\u201352. https:\/\/doi.org\/10.1002\/mrd.20359.","journal-title":"Wiley Online Library"},{"key":"2625_CR214","doi-asserted-by":"publisher","unstructured":"A. Bourret et al., \u201cBMP system expression in GCs from polycystic ovary syndrome women and the in vitro effects of BMP4, BMP6, and BMP7 on GC steroidogenesis,\u201d researchgate.net, 2012, https:\/\/doi.org\/10.1530\/EJE-12-0891.","DOI":"10.1530\/EJE-12-0891"},{"key":"2625_CR215","doi-asserted-by":"crossref","unstructured":"A. Fatehi, R. van den Hurk, B. C.- Theriogenology, and undefined 2005, \u201cExpression of bone morphogenetic protein2 (BMP2), BMP4 and BMP receptors in the bovine ovary but absence of effects of BMP2 and BMP4 during IVM on bovine,\u201d Elsevier, Accessed: Aug. 22, 2022. [Online]. Available: https:\/\/www.sciencedirect.com\/science\/article\/pii\/S0093691X04001645","DOI":"10.1016\/j.theriogenology.2004.05.013"},{"key":"2625_CR216","doi-asserted-by":"crossref","unstructured":"J. Visser, F. de Jong, \u2026 J. L.-, and undefined 2006, \u201cAnti-Mullerian hormone: a new marker for ovarian function,\u201d rep.bioscientifica.com, Accessed: Aug. 22, 2022. [Online]. Available: https:\/\/rep.bioscientifica.com\/view\/journals\/rep\/131\/1\/1310001.xml","DOI":"10.1530\/rep.1.00529"},{"key":"2625_CR217","doi-asserted-by":"publisher","unstructured":"E. L. A. F. van Houten, J. S. E. Laven, Y. v. Louwers, A. McLuskey, A. P. N. Themmen, and J. A. Visser, \u201cBone morphogenetic proteins and the polycystic ovary syndrome,\u201d Journal of Ovarian Research, 6, 1:1\u20134, 2013, https:\/\/doi.org\/10.1186\/1757-2215-6-32\/TABLES\/1.","DOI":"10.1186\/1757-2215-6-32\/TABLES\/1"},{"key":"2625_CR218","doi-asserted-by":"publisher","unstructured":"Y. Han et al., \u201cMesenchymal stem cells for regenerative medicine,\u201d mdpi.com, 2019, https:\/\/doi.org\/10.3390\/cells8080886.","DOI":"10.3390\/cells8080886"},{"key":"2625_CR219","doi-asserted-by":"publisher","unstructured":"J. Zhang et al., \u201cThe challenges and promises of allogeneic mesenchymal stem cells for use as a cell-based therapy,\u201d Stem Cell Research and Therapy, vol. 6, no. 1, Dec. 2015, doi: https:\/\/doi.org\/10.1186\/S13287-015-0240-9.","DOI":"10.1186\/S13287-015-0240-9"},{"key":"2625_CR220","doi-asserted-by":"publisher","unstructured":"M. Ullah, D. D. Liu, and A. S. Thakor, \u201cMesenchymal stromal cell homing: mechanisms and strategies for improvement,\u201d iScience, 15:421\u2013438, 2019, https:\/\/doi.org\/10.1016\/J.ISCI.2019.05.004.","DOI":"10.1016\/J.ISCI.2019.05.004"},{"issue":"12","key":"2625_CR221","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1002\/JGM.452","volume":"5","author":"A Chapel","year":"2003","unstructured":"Chapel A, et al. Mesenchymal stem cells home to injured tissues when co-infused with hematopoietic cells to treat a radiation-induced multi-organ failure syndrome. J Gene Med. 2003;5(12):1028\u201338. https:\/\/doi.org\/10.1002\/JGM.452.","journal-title":"J Gene Med"},{"key":"2625_CR222","doi-asserted-by":"publisher","unstructured":"A. J. Braga Osorio Gomes Salgado et al., \u201cAdipose tissue derived stem cells secretome: soluble factors and their roles in regenerative medicine,\u201d Current Stem Cell Research & Therapy, 5, 2:103\u2013110, 2010, https:\/\/doi.org\/10.2174\/157488810791268564.","DOI":"10.2174\/157488810791268564"},{"issue":"14","key":"2625_CR223","doi-asserted-by":"publisher","first-page":"2771","DOI":"10.1007\/S00018-020-03454-6","volume":"77","author":"XL Fan","year":"2020","unstructured":"Fan XL, Zhang Y, Li X, Fu QL. Mechanisms underlying the protective effects of mesenchymal stem cell-based therapy. Cell Mol Life Sci. 2020;77(14):2771\u201394. https:\/\/doi.org\/10.1007\/S00018-020-03454-6.","journal-title":"Cell Mol Life Sci"},{"key":"2625_CR224","doi-asserted-by":"crossref","unstructured":"Q. Xie et al., \u201cMesenchymal stem cells alleviate DHEA-induced polycystic ovary syndrome (PCOS) by inhibiting inflammation in mice,\u201d hindawi.com, Accessed: Aug. 22, 2022. [Online]. Available: https:\/\/www.hindawi.com\/journals\/sci\/2019\/9782373\/","DOI":"10.1155\/2019\/9782373"},{"key":"2625_CR225","doi-asserted-by":"publisher","unstructured":"Z. KALHORI, M. AZADBAKHT, M. SOLEIMANI MEHRANJANI, and M. A. SHARIATZADEH, \u201cImprovement of the folliculogenesis by transplantation of bone marrow mesenchymal stromal cells in mice with induced polycystic ovary syndrome,\u201d Cytotherapy, 20, 12:1445\u20131458, 2018, https:\/\/doi.org\/10.1016\/J.JCYT.2018.09.005","DOI":"10.1016\/J.JCYT.2018.09.005"},{"key":"2625_CR226","doi-asserted-by":"publisher","unstructured":"R. M. Chugh et al., \u201cMesenchymal stem cell therapy ameliorates metabolic dysfunction and restores fertility in a PCOS mouse model through interleukin-10,\u201d Stem Cell Research and Therapy, 12, 1, 2021, https:\/\/doi.org\/10.1186\/S13287-021-02472-W.","DOI":"10.1186\/S13287-021-02472-W"},{"issue":"3","key":"2625_CR227","doi-asserted-by":"publisher","first-page":"e0174224","DOI":"10.1371\/JOURNAL.PONE.0174224","volume":"12","author":"N Marti","year":"2017","unstructured":"Marti N, Bouchoucha N, Sauter KS, Fl\u00fcck CE. Resveratrol inhibits androgen production of human adrenocortical H295R cells by lowering CYP17 and CYP21 expression and activities. PLoS ONE. 2017;12(3):e0174224. https:\/\/doi.org\/10.1371\/JOURNAL.PONE.0174224.","journal-title":"PLoS ONE"},{"key":"2625_CR228","doi-asserted-by":"publisher","unstructured":"P Kempn\u00e1 G Hofer P Mullis CF-M Pharmacology undefined, 2007 Pioglitazone inhibits androgen production in NCI-H295R cells by regulating gene expression of CYP17 and HSD3B2 ASPET 2006https:\/\/doi.org\/10.1124\/mol.106.028902","DOI":"10.1124\/mol.106.028902"},{"key":"2625_CR229","unstructured":"I. Dilogo, J. Fiolin, P. A.-A. S. Letters, and undefined 2018, \u201cOsteogenic potency of secretome bone marrow derived mesenchymal stem cells: a literature review,\u201d ingentaconnect.com, Accessed: Aug. 22, 2022. [Online]. Available: https:\/\/www.ingentaconnect.com\/contentone\/asp\/asl\/2018\/00000024\/00000008\/art00148"},{"key":"2625_CR230","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.3727\/096368910X550215","volume":"20","author":"M Polacek","year":"2011","unstructured":"Polacek M, Bruun J-A, Elvenes J, Figenschau Y, Martinez I. The secretory profiles of cultured human articular chondrocytes and mesenchymal stem cells: implications for autologous cell transplantation strategies. Cell Transplant. 2011;20:1381\u201393. https:\/\/doi.org\/10.3727\/096368910X550215.","journal-title":"Cell Transplant"},{"issue":"15","key":"2625_CR231","doi-asserted-by":"publisher","first-page":"5426","DOI":"10.1073\/PNAS.0409533102","volume":"102","author":"O Hashimoto","year":"2005","unstructured":"Hashimoto O, Moore RK, Shimasaki S. Posttranslational processing of mouse and human BMP-15: potential implication in the determination of ovulation quota. Proc Natl Acad Sci. 2005;102(15):5426\u201331. https:\/\/doi.org\/10.1073\/PNAS.0409533102.","journal-title":"Proc Natl Acad Sci"},{"issue":"1","key":"2625_CR232","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s12522-010-0072-3","volume":"10","author":"O Yoshino","year":"2011","unstructured":"Yoshino O, et al. The function of bone morphogenetic proteins in the human ovary. Springer. 2011;10(1):1\u20137. https:\/\/doi.org\/10.1007\/s12522-010-0072-3.","journal-title":"Springer"},{"key":"2625_CR233","doi-asserted-by":"publisher","unstructured":"N. Xu et al., \u201cEpigenetic mechanism underlying the development of polycystic ovary syndrome (PCOS)-like phenotypes in prenatally androgenized rhesus monkeys,\u201d PLoS ONE, 6, 11, 2011, https:\/\/doi.org\/10.1371\/JOURNAL.PONE.0027286.","DOI":"10.1371\/JOURNAL.PONE.0027286"},{"key":"2625_CR234","doi-asserted-by":"publisher","unstructured":"A. A. Bremer, \u201cPolycystic ovary syndrome in the pediatric population,\u201d https:\/\/home.liebertpub.com\/met, vol. 8, no. 5, pp. 375\u2013394, Oct. 2010, doi: https:\/\/doi.org\/10.1089\/MET.2010.0039.","DOI":"10.1089\/MET.2010.0039"},{"key":"2625_CR235","doi-asserted-by":"crossref","unstructured":"R. Rosenfield, D. E.-E. reviews, and undefined 2016, \u201cThe pathogenesis of polycystic ovary syndrome (PCOS): the hypothesis of PCOS as functional ovarian hyperandrogenism revisited,\u201d academic.oup.com, Accessed: Aug. 22, 2022. [Online]. Available: https:\/\/academic.oup.com\/edrv\/article-abstract\/37\/5\/467\/2567094","DOI":"10.1210\/er.2015-1104"},{"issue":"2","key":"2625_CR236","doi-asserted-by":"publisher","first-page":"184","DOI":"10.7150\/IJMS.3859","volume":"9","author":"J Zhang","year":"2012","unstructured":"Zhang J, et al. Effect of bone morphogenetic protein-2 on proliferation and apoptosis of gastric cancer cells. Int J Med Sci. 2012;9(2):184. https:\/\/doi.org\/10.7150\/IJMS.3859.","journal-title":"Int J Med Sci"},{"key":"2625_CR237","doi-asserted-by":"crossref","unstructured":"J. Hardwick, G. van den Brink, S. B.- Gastroenterology, and undefined 2004, \u201cBone morphogenetic protein 2 is expressed by, and acts upon, mature epithelial cells in the colon,\u201d Elsevier, Accessed: Aug. 22, 2022. [Online]. Available: https:\/\/www.sciencedirect.com\/science\/article\/pii\/S0016508503017359","DOI":"10.1016\/S0016-5085(03)82315-6"},{"key":"2625_CR238","doi-asserted-by":"crossref","unstructured":"R. Chugh, H. Park, S. Esfandyari, \u2026 A. E.-I. journal of, and undefined 2021, \u201cMesenchymal stem cell-conditioned media regulate steroidogenesis and inhibit androgen secretion in a PCOS cell model via BMP-2,\u201d mdpi.com, Accessed: Aug. 22, 2022. [Online]. Available: https:\/\/www.mdpi.com\/1243468","DOI":"10.3390\/ijms22179184"},{"key":"2625_CR239","doi-asserted-by":"crossref","unstructured":"M. Sewer, M. W.- Endocrinology, and undefined 2002, \u201cAdrenocorticotropin\/cyclic adenosine 3\u2032, 5\u2032-monophosphate-mediated transcription of the human CYP17 gene in the adrenal cortex is dependent on phosphatase,\u201d academic.oup.com, Accessed: Aug. 22, 2022. [Online]. Available: https:\/\/academic.oup.com\/endo\/article-abstract\/143\/5\/1769\/2989540","DOI":"10.1210\/endo.143.5.8820"},{"key":"2625_CR240","doi-asserted-by":"crossref","unstructured":"P. Kempn\u00e1, G. Hofer, P. Mullis, C. F.-M. Pharmacology, and undefined 2007, \u201cPioglitazone inhibits androgen production in NCI-H295R cells by regulating gene expression of CYP17 and HSD3B2,\u201d ASPET, Accessed: Aug. 22, 2022. [Online]. Available: https:\/\/molpharm.aspetjournals.org\/content\/71\/3\/787.short","DOI":"10.1124\/mol.106.028902"},{"issue":"3","key":"2625_CR241","doi-asserted-by":"publisher","first-page":"201","DOI":"10.3109\/09513590.2015.1106470","volume":"32","author":"X Huang","year":"2016","unstructured":"Huang X, et al. Modulation of expression of 17-Hydroxylase\/17,20 lyase (CYP17) and P450 aromatase (CYP19) by inhibition of MEK1 in a human ovarian granulosa-like tumor cell line. Gynecol Endocrinol. 2016;32(3):201\u20135. https:\/\/doi.org\/10.3109\/09513590.2015.1106470.","journal-title":"Gynecol Endocrinol"},{"key":"2625_CR242","doi-asserted-by":"publisher","unstructured":"F. Diomede et al., \u201cNon-cytokine protein profile of the mesenchymal stem cell secretome that regulates the androgen production pathway,\u201d mdpi.com, 2022, doi: https:\/\/doi.org\/10.3390\/ijms23094633.","DOI":"10.3390\/ijms23094633"},{"key":"2625_CR243","unstructured":"C. DeUgarte, A. Bartolucci, R. A.-F. and sterility, and undefined 2005, \u201cPrevalence of insulin resistance in the polycystic ovary syndrome using the homeostasis model assessment,\u201d Elsevier, Accessed: Aug. 22, 2022. [Online]. Available: https:\/\/www.sciencedirect.com\/science\/article\/pii\/S0015028205003730?casa_token=5wfGPsSz3xUAAAAA:kvoTklN6j9wD9udaRIAdKHWe6XQn-ItidYYoUWLB76_9p34ULtUGXm-WLyOZRdppdVwCPVjUf7g"},{"key":"2625_CR244","doi-asserted-by":"publisher","unstructured":"M. \u00c1ngeles Mart\u00ednez-Garc\u00eda, S. Moncayo, M. Insenser, F. \u00c1lvarez-Blasco, M. Luque-Ram\u00edrez, and H. F. Escobar-Morreale, \u201cMetabolic cytokines at fasting and during macronutrient challenges: influence of obesity, female androgen excess and sex,\u201d mdpi.com, vol. 11, p. 2566, 2019, doi: https:\/\/doi.org\/10.3390\/nu11112566.","DOI":"10.3390\/nu11112566"},{"issue":"6","key":"2625_CR245","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1210\/ER.2011-1034","volume":"33","author":"E Diamanti-Kandarakis","year":"2012","unstructured":"Diamanti-Kandarakis E, Dunaif A. Insulin resistance and the polycystic ovary syndrome revisited: an update on mechanisms and implications. Endocr Rev. 2012;33(6):981\u20131030. https:\/\/doi.org\/10.1210\/ER.2011-1034.","journal-title":"Endocr Rev"},{"key":"2625_CR246","doi-asserted-by":"publisher","unstructured":"A. C. McPherron, A. M. Lawler, and S. J. Lee, \u201cRegulation of skeletal muscle mass in mice by a new TGF-p superfamily member,\u201d Nature 1997 387:6628, vol. 387, no. 6628, pp. 83\u201390, May 1997, doi: https:\/\/doi.org\/10.1038\/387083a0.","DOI":"10.1038\/387083a0"},{"key":"2625_CR247","doi-asserted-by":"crossref","unstructured":"H. Chang, J. Qiao, P. L.-H. reproduction update, and undefined 2017, \u201cOocyte\u2013somatic cell interactions in the human ovary\u2014novel role of bone morphogenetic proteins and growth differentiation factors,\u201d academic.oup.com, Accessed: Aug. 22, 2022. [Online]. Available: https:\/\/academic.oup.com\/humupd\/article-abstract\/23\/1\/1\/2334872","DOI":"10.1093\/humupd\/dmw039"},{"issue":"5","key":"2625_CR248","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1172\/JCI13562","volume":"109","author":"AC McPherron","year":"2002","unstructured":"McPherron AC, Lee S-J. Suppression of body fat accumulation in myostatin-deficient mice. J Clin Investig. 2002;109(5):595\u2013601. https:\/\/doi.org\/10.1172\/JCI13562.","journal-title":"J Clin Investig"},{"issue":"2","key":"2625_CR249","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1152\/PHYSIOLGENOMICS.00045.2006","volume":"27","author":"JJ Park","year":"2006","unstructured":"Park JJ, Berggren JR, Hulver MW, Houmard JA, Hoffman EP. GRB14, GPD1, and GDF8 as potential network collaborators in weight loss-induced improvements in insulin action in human skeletal muscle. Physiol Genomics. 2006;27(2):114\u201321. https:\/\/doi.org\/10.1152\/PHYSIOLGENOMICS.00045.2006.","journal-title":"Physiol Genomics"},{"key":"2625_CR250","doi-asserted-by":"crossref","unstructured":"L. Bai, W. Wang, Y. Xiang, S. Wang, \u2026 S. W.-M. T.-N., and undefined 2021, \u201cAberrant elevation of GDF8 impairs granulosa cell glucose metabolism via upregulating SERPINE1 expression in patients with PCOS,\u201d Elsevier, Accessed: Aug. 22, 2022. [Online]. Available: https:\/\/www.sciencedirect.com\/science\/article\/pii\/S2162253120303619","DOI":"10.1016\/j.omtn.2020.11.005"},{"key":"2625_CR251","doi-asserted-by":"publisher","unstructured":"S. Risal et al., \u201cPrenatal androgen exposure and transgenerational susceptibility to polycystic ovary syndrome,\u201d Nature Medicine 2019 25:12, vol. 25, no. 12, pp. 1894\u20131904, Dec. 2019, doi: https:\/\/doi.org\/10.1038\/s41591-019-0666-1.","DOI":"10.1038\/s41591-019-0666-1"},{"key":"2625_CR252","doi-asserted-by":"publisher","unstructured":"Y. Shi et al., \u201cGenome-wide association study identifies eight new risk loci for polycystic ovary syndrome,\u201d Nature Genetics 2012 44:9, vol. 44, no. 9, pp. 1020\u20131025, Aug. 2012, doi: https:\/\/doi.org\/10.1038\/ng.2384.","DOI":"10.1038\/ng.2384"},{"key":"2625_CR253","unstructured":"Z. Chen et al., \u201cGenome-wide association study identifies susceptibility loci for polycystic ovary syndrome on chromosome 2p16. 3, 2p21 and 9q33. 3,\u201d nature.com, Accessed: Aug. 22, 2022. [Online]. Available: https:\/\/www.nature.com\/articles\/ng.732"},{"issue":"2","key":"2625_CR254","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1210\/JC.2006-2123","volume":"92","author":"JR Wood","year":"2007","unstructured":"Wood JR, Dumesic DA, Abbott DH, Strauss JF. Molecular abnormalities in oocytes from women with polycystic ovary syndrome revealed by microarray analysis. J Clin Endocrinol Metab. 2007;92(2):705\u201313. https:\/\/doi.org\/10.1210\/JC.2006-2123.","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"2625_CR255","doi-asserted-by":"publisher","first-page":"3523","DOI":"10.1093\/HUMREP\/DES325","volume":"27","author":"D Haouzi","year":"2012","unstructured":"Haouzi D, Assou S, Monzo C, Vincens C, Dechaud H, Hamamah S. Altered gene expression profile in cumulus cells of mature MII oocytes from patients with polycystic ovary syndrome. Hum Reprod. 2012;27(12):3523\u201330. https:\/\/doi.org\/10.1093\/HUMREP\/DES325.","journal-title":"Hum Reprod"},{"key":"2625_CR256","doi-asserted-by":"publisher","unstructured":"J. Li et al., \u201cMolecular features of polycystic ovary syndrome revealed by transcriptome analysis of oocytes and cumulus cells,\u201d Frontiers in Cell and Developmental Biology, vol. 9, Sep. 2021, doi: https:\/\/doi.org\/10.3389\/FCELL.2021.735684\/FULL.","DOI":"10.3389\/FCELL.2021.735684\/FULL"},{"key":"2625_CR257","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/J.BCP.2019.03.030","volume":"165","author":"V Francisco","year":"2019","unstructured":"Francisco V, et al. Adipokines: Linking metabolic syndrome, the immune system, and arthritic diseases. Biochem Pharmacol. 2019;165:196\u2013206. https:\/\/doi.org\/10.1016\/J.BCP.2019.03.030.","journal-title":"Biochem Pharmacol"},{"issue":"1","key":"2625_CR258","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/S12966-018-0761-6\/FIGURES\/3","volume":"16","author":"TM van Elten","year":"2019","unstructured":"van Elten TM, et al. Preconception lifestyle intervention reduces long term energy intake in women with obesity and infertility: a randomised controlled trial 11 Medical and Health Sciences 1117 Public Health and Health Services 11 Medical and Health Sciences 1111 Nutrition and Dietetics. Int J Behav Nutr Phys Act. 2019;16(1):1\u201310. https:\/\/doi.org\/10.1186\/S12966-018-0761-6\/FIGURES\/3.","journal-title":"Int J Behav Nutr Phys Act"},{"issue":"9","key":"2625_CR259","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1038\/nm.2885","volume":"18","author":"S Talukdar","year":"2012","unstructured":"Talukdar S, et al. Neutrophils mediate insulin resistance in mice fed a high-fat diet through secreted elastase. Nature Med. 2012;18(9):1407\u201312. https:\/\/doi.org\/10.1038\/nm.2885.","journal-title":"Nature Med."},{"key":"2625_CR260","doi-asserted-by":"publisher","unstructured":"N. J. Su et al., \u201cThe peripheral blood transcriptome identifies dysregulation of inflammatory response genes in polycystic ovary syndrome,\u201d https:\/\/doi.org\/10.1080\/09513590.2017.1418851, 34, 7:584\u2013588, 2017, https:\/\/doi.org\/10.1080\/09513590.2017.1418851.","DOI":"10.1080\/09513590.2017.1418851 10.1080\/09513590.2017.1418851"},{"issue":"4","key":"2625_CR261","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1016\/J.STEROIDS.2011.12.003","volume":"77","author":"F Gonz\u00e1lez","year":"2012","unstructured":"Gonz\u00e1lez F. Inflammation in polycystic ovary syndrome: underpinning of insulin resistance and ovarian dysfunction. Steroids. 2012;77(4):300\u20135. https:\/\/doi.org\/10.1016\/J.STEROIDS.2011.12.003.","journal-title":"Steroids"},{"issue":"3","key":"2625_CR262","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/J.YHBEH.2012.06.005","volume":"62","author":"SD Bilbo","year":"2012","unstructured":"Bilbo SD, Klein SL. special issue: the neuroendocrine-immune axis in health and disease. Horm Behav. 2012;62(3):187\u201390. https:\/\/doi.org\/10.1016\/J.YHBEH.2012.06.005.","journal-title":"Horm Behav"},{"issue":"3","key":"2625_CR263","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1038\/nrm3531","volume":"14","author":"R Li","year":"2013","unstructured":"Li R, Albertini DF. The road to maturation: somatic cell interaction and self-organization of the mammalian oocyte. Nature Rev Mol Cell Biol. 2013;14(3):141\u201352. https:\/\/doi.org\/10.1038\/nrm3531.","journal-title":"Nature Rev Mol Cell Biol"},{"key":"2625_CR264","doi-asserted-by":"publisher","unstructured":"L. A. Jaffe and J. R. Egbert, \u201cRegulation of mammalian oocyte meiosis by intercellular communication within the ovarian follicle,\u201d http:\/\/dx.doi.org\/https:\/\/doi.org\/10.1146\/annurev-physiol-022516-034102, 79, 237\u2013260, 2017, https:\/\/doi.org\/10.1146\/ANNUREV-PHYSIOL-022516-034102.","DOI":"10.1146\/annurev-physiol-022516-034102 10.1146\/ANNUREV-PHYSIOL-022516-034102"},{"issue":"4","key":"2625_CR265","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1055\/S-0035-1554928\/ID\/JR00947A-42","volume":"33","author":"CE Boots","year":"2015","unstructured":"Boots CE, Jungheim ES. Inflammation and human ovarian follicular dynamics. Sem Reprod Med. 2015;33(4):270\u20135. https:\/\/doi.org\/10.1055\/S-0035-1554928\/ID\/JR00947A-42.","journal-title":"Sem Reprod Med"},{"issue":"2","key":"2625_CR266","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1210\/ER.2018-00075","volume":"40","author":"DM Duffy","year":"2019","unstructured":"Duffy DM, Ko C, Jo M, Brannstrom M, Curry TE. Ovulation: parallels with inflammatory processes. Endocr Rev. 2019;40(2):369\u2013416. https:\/\/doi.org\/10.1210\/ER.2018-00075.","journal-title":"Endocr Rev"},{"issue":"6","key":"2625_CR267","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1016\/J.CELL.2020.02.041","volume":"180","author":"KA Fitzgerald","year":"2020","unstructured":"Fitzgerald KA, Kagan JC. Toll-like receptors and the control of immunity. Cell. 2020;180(6):1044\u201366. https:\/\/doi.org\/10.1016\/J.CELL.2020.02.041.","journal-title":"Cell"},{"issue":"8","key":"2625_CR268","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1038\/nri2587","volume":"9","author":"GM Barton","year":"2009","unstructured":"Barton GM, Kagan JC. A cell biological view of Toll-like receptor function: regulation through compartmentalization. Nature Rev Immunol. 2009;9(8):535\u201342. https:\/\/doi.org\/10.1038\/nri2587.","journal-title":"Nature Rev Immunol"},{"key":"2625_CR269","doi-asserted-by":"crossref","unstructured":"K. Hoshino et al., \u201cCutting Edge: Toll-like receptor 4 (TLR4)-deficient mice are hyporesponsive to lipopolysaccharide: evidence for TLR4 as the lps gene product,\u201d The Journal of Immunology, 162, 7, 1999","DOI":"10.4049\/jimmunol.162.7.3749"},{"key":"2625_CR270","doi-asserted-by":"publisher","unstructured":"K. v. Swanson, M. Deng, and J. P. Y. Ting, \u201cThe NLRP3 inflammasome: molecular activation and regulation to therapeutics,\u201d Nature Reviews Immunology, 19, 8:477\u2013489, 2019, https:\/\/doi.org\/10.1038\/s41577-019-0165-0","DOI":"10.1038\/s41577-019-0165-0"},{"key":"2625_CR271","doi-asserted-by":"publisher","first-page":"211","DOI":"10.3389\/FIMMU.2020.00211\/BIBTEX","volume":"11","author":"C Zhao","year":"2020","unstructured":"Zhao C, Zhao W. NLRP3 inflammasome\u2014a key player in antiviral responses. Front Immunol. 2020;11:211. https:\/\/doi.org\/10.3389\/FIMMU.2020.00211\/BIBTEX.","journal-title":"Front Immunol"},{"key":"2625_CR272","doi-asserted-by":"publisher","unstructured":"M. H. Park and J. T. Hong, \u201cRoles of NF-\u03baB in cancer and inflammatory diseases and their therapeutic approaches,\u201d Cells 2016, 5, 15, 5, 2, 15, 2016, https:\/\/doi.org\/10.3390\/CELLS5020015","DOI":"10.3390\/CELLS5020015"},{"issue":"2","key":"2625_CR273","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/S1097-2765(02)00599-3","volume":"10","author":"F Martinon","year":"2002","unstructured":"Martinon F, Burns K, Tschopp J. The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-\u03b2. Mol Cell. 2002;10(2):417\u201326. https:\/\/doi.org\/10.1016\/S1097-2765(02)00599-3.","journal-title":"Mol Cell"},{"issue":"4","key":"2625_CR274","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1007\/S00281-019-00737-4\/FIGURES\/2","volume":"41","author":"M Popovic","year":"2019","unstructured":"Popovic M, Sartorius G, Christ-Crain M. Chronic low-grade inflammation in polycystic ovary syndrome: is there a (patho)-physiological role for interleukin-1? Seminars in Immunopathology. 2019;41(4):447\u201359. https:\/\/doi.org\/10.1007\/S00281-019-00737-4\/FIGURES\/2.","journal-title":"Seminars in Immunopathology"},{"key":"2625_CR275","doi-asserted-by":"publisher","first-page":"1710","DOI":"10.3389\/FENDO.2021.787854\/BIBTEX","volume":"12","author":"S Li","year":"2021","unstructured":"Li S, Zhang L, Wei N, Tai Z, Yu C, Xu Z. Research progress on the effect of epilepsy and antiseizure medications on PCOS through HPO Axis. Front Endocrinol. 2021;12:1710. https:\/\/doi.org\/10.3389\/FENDO.2021.787854\/BIBTEX.","journal-title":"Front Endocrinol"},{"key":"2625_CR276","doi-asserted-by":"publisher","unstructured":"L. Jin, J. Yu, Y. Chen, H. Pang, J. Sheng, and H. Huang, \u201cPolycystic ovary syndrome and risk of five common psychiatric disorders among European women: a two-sample Mendelian randomization study,\u201d Frontiers in Genetics, 12, 2021, https:\/\/doi.org\/10.3389\/FGENE.2021.689897\/FULL","DOI":"10.3389\/FGENE.2021.689897\/FULL"},{"key":"2625_CR277","doi-asserted-by":"crossref","unstructured":"T. Sir-Petermann, M. Maliqueo, \u2026 E. C.-T. J. of, and undefined 2007, \u201cEarly metabolic derangements in daughters of women with polycystic ovary syndrome,\u201d academic.oup.com, Accessed: Aug. 22, 2022. [Online]. Available: https:\/\/academic.oup.com\/jcem\/article-abstract\/92\/12\/4637\/2597088","DOI":"10.1210\/jc.2007-1036"},{"issue":"7","key":"2625_CR278","doi-asserted-by":"publisher","first-page":"2283","DOI":"10.1210\/JCEM.82.7.4084","volume":"82","author":"L Ib\u00e1\u00f1ez","year":"1997","unstructured":"Ib\u00e1\u00f1ez L, Potau N, Zampolli M, Riqu\u00c9 S, Saenger P, Carrascosa A. Hyperinsulinemia and decreased insulin-like growth factor-binding protein-1 are common features in prepubertal and pubertal girls with a history of premature pubarche. J Clin Endocrinol Metab. 1997;82(7):2283\u20138. https:\/\/doi.org\/10.1210\/JCEM.82.7.4084.","journal-title":"J Clin Endocrinol Metab"},{"key":"2625_CR279","doi-asserted-by":"crossref","unstructured":"S. Persson, E. Elenis, S. Turkmen, \u2026 M. K.-H., and undefined 2019, \u201cFecundity among women with polycystic ovary syndrome (PCOS)\u2014a population-based study,\u201d academic.oup.com, Accessed: Aug. 22, 2022. [Online]. Available: https:\/\/academic.oup.com\/humrep\/article-abstract\/34\/10\/2052\/5556931","DOI":"10.1093\/humrep\/dez159"},{"key":"2625_CR280","doi-asserted-by":"publisher","unstructured":"E. Elenis, E. Desroziers, S. Persson, I. Sundstr\u00f6m Poromaa, and R. E. Campbell, \u201cEarly initiation of anti-androgen treatment is associated with increased probability of spontaneous conception leading to childbirth in women with polycystic ovary syndrome: a population-based multiregistry cohort study in Sweden,\u201d Human Reproduction, 36, 5:1427\u20131435, 2021, https:\/\/doi.org\/10.1093\/HUMREP\/DEAA357","DOI":"10.1093\/HUMREP\/DEAA357"}],"container-title":["Journal of Assisted Reproduction and Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10815-022-02625-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10815-022-02625-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10815-022-02625-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,21]],"date-time":"2023-02-21T11:39:31Z","timestamp":1676979571000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10815-022-02625-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,3]]},"references-count":280,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2022,11]]}},"alternative-id":["2625"],"URL":"https:\/\/doi.org\/10.1007\/s10815-022-02625-7","relation":{},"ISSN":["1058-0468","1573-7330"],"issn-type":[{"value":"1058-0468","type":"print"},{"value":"1573-7330","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,3]]},"assertion":[{"value":"6 June 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 September 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 October 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study does not involve human participants, their data or biological material.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interest"}}]}}